Motif 796 (n=107)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NKT7 | RGPD3 | T1017 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
A6QL64 | ANKRD36 | S478 | ochoa | Ankyrin repeat domain-containing protein 36A | None |
O00522 | KRIT1 | S261 | ochoa | Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein) | Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1; this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels. May play a role in the regulation of macroautophagy through the down-regulation of the mTOR pathway (PubMed:26417067). {ECO:0000250|UniProtKB:Q6S5J6, ECO:0000269|PubMed:11741838, ECO:0000269|PubMed:17916086, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:20616044, ECO:0000269|PubMed:20668652, ECO:0000269|PubMed:21633110, ECO:0000269|PubMed:23317506, ECO:0000269|PubMed:26417067}. |
O14715 | RGPD8 | T1016 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O43683 | BUB1 | S969 | ochoa|psp | Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A) | Serine/threonine-protein kinase that performs 2 crucial functions during mitosis: it is essential for spindle-assembly checkpoint signaling and for correct chromosome alignment. Has a key role in the assembly of checkpoint proteins at the kinetochore, being required for the subsequent localization of CENPF, BUB1B, CENPE and MAD2L1. Required for the kinetochore localization of PLK1. Required for centromeric enrichment of AUKRB in prometaphase. Plays an important role in defining SGO1 localization and thereby affects sister chromatid cohesion. Promotes the centromeric localization of TOP2A (PubMed:35044816). Acts as a substrate for anaphase-promoting complex or cyclosome (APC/C) in complex with its activator CDH1 (APC/C-Cdh1). Necessary for ensuring proper chromosome segregation and binding to BUB3 is essential for this function. Can regulate chromosome segregation in a kinetochore-independent manner. Can phosphorylate BUB3. The BUB1-BUB3 complex plays a role in the inhibition of APC/C when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1. Kinase activity is essential for inhibition of APC/CCDC20 and for chromosome alignment but does not play a major role in the spindle-assembly checkpoint activity. Mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. {ECO:0000269|PubMed:10198256, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:15525512, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:16760428, ECO:0000269|PubMed:17158872, ECO:0000269|PubMed:19487456, ECO:0000269|PubMed:20739936, ECO:0000269|PubMed:35044816}. |
O60711 | LPXN | S267 | ochoa | Leupaxin | Transcriptional coactivator for androgen receptor (AR) and serum response factor (SRF). Contributes to the regulation of cell adhesion, spreading and cell migration and acts as a negative regulator in integrin-mediated cell adhesion events. Suppresses the integrin-induced tyrosine phosphorylation of paxillin (PXN). May play a critical role as an adapter protein in the formation of the adhesion zone in osteoclasts. Negatively regulates B-cell antigen receptor (BCR) signaling. {ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:18451096, ECO:0000269|PubMed:18497331, ECO:0000269|PubMed:20543562}. |
O75475 | PSIP1 | S482 | ochoa | PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52) | Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration. {ECO:0000269|PubMed:15642333}. |
O94762 | RECQL5 | S954 | ochoa | ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) | DNA helicase that plays an important role in DNA replication, transcription and repair (PubMed:20643585, PubMed:22973052, PubMed:28100692). Probably unwinds DNA in a 3'-5' direction (Probable) (PubMed:28100692). Binds to the RNA polymerase II subunit POLR2A during transcription elongation and suppresses transcription-associated genomic instability (PubMed:20231364). Also associates with POLR1A and enforces the stability of ribosomal DNA arrays (PubMed:27502483). Plays an important role in mitotic chromosome separation after cross-over events and cell cycle progress (PubMed:22013166). Mechanistically, removes RAD51 filaments protecting stalled replication forks at common fragile sites and stimulates MUS81-EME1 endonuclease leading to mitotic DNA synthesis (PubMed:28575661). Required for efficient DNA repair, including repair of inter-strand cross-links (PubMed:23715498). Stimulates DNA decatenation mediated by TOP2A. Prevents sister chromatid exchange and homologous recombination. A core helicase fragment (residues 11-609) binds preferentially to splayed duplex, looped and ssDNA (PubMed:28100692). {ECO:0000269|PubMed:20231364, ECO:0000269|PubMed:20348101, ECO:0000269|PubMed:20643585, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22973052, ECO:0000269|PubMed:23715498, ECO:0000269|PubMed:23748380, ECO:0000269|PubMed:27502483, ECO:0000269|PubMed:28100692, ECO:0000269|PubMed:28575661, ECO:0000305|PubMed:28100692}. |
O94832 | MYO1D | S493 | ochoa | Unconventional myosin-Id | Unconventional myosin that functions as actin-based motor protein with ATPase activity (By similarity). Plays a role in endosomal protein trafficking, and especially in the transfer of cargo proteins from early to recycling endosomes (By similarity). Required for normal planar cell polarity in ciliated tracheal cells, for normal rotational polarity of cilia, and for coordinated, unidirectional ciliary movement in the trachea. Required for normal, polarized cilia organization in brain ependymal epithelial cells (By similarity). {ECO:0000250|UniProtKB:F1PRN2, ECO:0000250|UniProtKB:Q63357}. |
O95359 | TACC2 | S1822 | ochoa | Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). May play a role in organizing centrosomal microtubules. May act as a tumor suppressor protein. May represent a tumor progression marker. {ECO:0000250, ECO:0000269|PubMed:10749935}. |
O95400 | CD2BP2 | S39 | ochoa | CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K) | Involved in pre-mRNA splicing as component of the U5 snRNP complex that is involved in spliceosome assembly. {ECO:0000269|PubMed:15840814}. |
P00352 | ALDH1A1 | S413 | ochoa | Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.3) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1) (RALDH 1) (RalDH1) | Cytosolic dehydrogenase that catalyzes the irreversible oxidation of a wide range of aldehydes to their corresponding carboxylic acid (PubMed:12941160, PubMed:15623782, PubMed:17175089, PubMed:19296407, PubMed:25450233, PubMed:26373694). Functions downstream of retinol dehydrogenases and catalyzes the oxidation of retinaldehyde into retinoic acid, the second step in the oxidation of retinol/vitamin A into retinoic acid (By similarity). This pathway is crucial to control the levels of retinol and retinoic acid, two important molecules which excess can be teratogenic and cytotoxic (By similarity). Also oxidizes aldehydes resulting from lipid peroxidation like (E)-4-hydroxynon-2-enal/HNE, malonaldehyde and hexanal that form protein adducts and are highly cytotoxic. By participating for instance to the clearance of (E)-4-hydroxynon-2-enal/HNE in the lens epithelium prevents the formation of HNE-protein adducts and lens opacification (PubMed:12941160, PubMed:15623782, PubMed:19296407). Also functions downstream of fructosamine-3-kinase in the fructosamine degradation pathway by catalyzing the oxidation of 3-deoxyglucosone, the carbohydrate product of fructosamine 3-phosphate decomposition, which is itself a potent glycating agent that may react with lysine and arginine side-chains of proteins (PubMed:17175089). Also has an aminobutyraldehyde dehydrogenase activity and is probably part of an alternative pathway for the biosynthesis of GABA/4-aminobutanoate in midbrain, thereby playing a role in GABAergic synaptic transmission (By similarity). {ECO:0000250|UniProtKB:P24549, ECO:0000269|PubMed:12941160, ECO:0000269|PubMed:15623782, ECO:0000269|PubMed:17175089, ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:25450233, ECO:0000269|PubMed:26373694}. |
P06239 | LCK | S194 | ochoa|psp | Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) | Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Interacts with FYB2 (PubMed:27335501). {ECO:0000269|PubMed:16339550, ECO:0000269|PubMed:16709819, ECO:0000269|PubMed:20028775, ECO:0000269|PubMed:20100835, ECO:0000269|PubMed:20851766, ECO:0000269|PubMed:21269457, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:27335501, ECO:0000269|PubMed:38614099}. |
P06748 | NPM1 | S88 | ochoa|psp | Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029). May act as chaperonin or cotransporter in the nucleolar localization of transcription termination factor TTF1 (By similarity). {ECO:0000250|UniProtKB:Q61937, ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:16107701, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:18809582, ECO:0000269|PubMed:19188445, ECO:0000269|PubMed:20352051, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:22002061, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25956029}. |
P06748 | NPM1 | S149 | ochoa | Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029). May act as chaperonin or cotransporter in the nucleolar localization of transcription termination factor TTF1 (By similarity). {ECO:0000250|UniProtKB:Q61937, ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:16107701, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:18809582, ECO:0000269|PubMed:19188445, ECO:0000269|PubMed:20352051, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:22002061, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25956029}. |
P06748 | NPM1 | S227 | ochoa | Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029). May act as chaperonin or cotransporter in the nucleolar localization of transcription termination factor TTF1 (By similarity). {ECO:0000250|UniProtKB:Q61937, ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:16107701, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:18809582, ECO:0000269|PubMed:19188445, ECO:0000269|PubMed:20352051, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:22002061, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25956029}. |
P07197 | NEFM | S736 | ochoa | Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein) | Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. May additionally cooperate with the neuronal intermediate filament proteins PRPH and INA to form neuronal filamentous networks (By similarity). {ECO:0000250|UniProtKB:P08553}. |
P07948 | LYN | S228 | ochoa | Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) | Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Involved in the regulation of endothelial activation, neutrophil adhesion and transendothelial migration (PubMed:36932076). Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Phosphorylates SCIMP on 'Tyr-107'; this enhances binding of SCIMP to TLR4, promoting the phosphorylation of TLR4, and a selective cytokine response to lipopolysaccharide in macrophages (By similarity). Phosphorylates CLNK (By similarity). Phosphorylates BCAR1/CAS and NEDD9/HEF1 (PubMed:9020138). {ECO:0000250|UniProtKB:P25911, ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:10748115, ECO:0000269|PubMed:10891478, ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:11825908, ECO:0000269|PubMed:14726379, ECO:0000269|PubMed:15795233, ECO:0000269|PubMed:16467205, ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:17977829, ECO:0000269|PubMed:18056483, ECO:0000269|PubMed:18070987, ECO:0000269|PubMed:18235045, ECO:0000269|PubMed:18577747, ECO:0000269|PubMed:18802065, ECO:0000269|PubMed:19290919, ECO:0000269|PubMed:20037584, ECO:0000269|PubMed:36122175, ECO:0000269|PubMed:36932076, ECO:0000269|PubMed:7687428, ECO:0000269|PubMed:9020138}. |
P0DJD0 | RGPD1 | T1001 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | T1009 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P15822 | HIVEP1 | S476 | ochoa | Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV-1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, and interferon-beta genes. It may act in T-cell activation. Involved in activating HIV-1 gene expression. Isoform 2 and isoform 3 also bind to the IPCS (IRF1 and p53 common sequence) DNA sequence in the promoter region of interferon regulatory factor 1 and p53 genes and are involved in transcription regulation of these genes. Isoform 2 does not activate HIV-1 gene expression. Isoform 2 and isoform 3 may be involved in apoptosis. |
P17041 | ZNF32 | S69 | ochoa | Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30) | May be involved in transcriptional regulation. |
P17252 | PRKCA | S319 | ochoa | Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) | Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. During chemokine-induced CD4(+) T cell migration, phosphorylates CDC42-guanine exchange factor DOCK8 resulting in its dissociation from LRCH1 and the activation of GTPase CDC42 (PubMed:28028151). Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription. Phosphorylates SOCS2 at 'Ser-52' facilitating its ubiquitination and proteasomal degradation (By similarity). Phosphorylates KLHL3 in response to angiotensin II signaling, decreasing the interaction between KLHL3 and WNK4 (PubMed:25313067). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231). {ECO:0000250|UniProtKB:P20444, ECO:0000269|PubMed:10848585, ECO:0000269|PubMed:11909826, ECO:0000269|PubMed:12724315, ECO:0000269|PubMed:12832403, ECO:0000269|PubMed:15016832, ECO:0000269|PubMed:15504744, ECO:0000269|PubMed:15526160, ECO:0000269|PubMed:18056764, ECO:0000269|PubMed:19176525, ECO:0000269|PubMed:21576361, ECO:0000269|PubMed:21806543, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:25313067, ECO:0000269|PubMed:28028151, ECO:0000269|PubMed:36040231, ECO:0000269|PubMed:9738012, ECO:0000269|PubMed:9830023, ECO:0000269|PubMed:9873035, ECO:0000269|PubMed:9927633}. |
P17677 | GAP43 | S41 | ochoa | Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) | This protein is associated with nerve growth. It is a major component of the motile 'growth cones' that form the tips of elongating axons. Plays a role in axonal and dendritic filopodia induction. {ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:21152083}. |
P25054 | APC | S2064 | ochoa | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000250|UniProtKB:Q61315, ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17293347, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}. |
P25705 | ATP5F1A | S254 | ochoa | ATP synthase F(1) complex subunit alpha, mitochondrial (ATP synthase F1 subunit alpha) | Subunit alpha, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1) region and a stationary peripheral stalk (PubMed:37244256). During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (Probable). In vivo, can only synthesize ATP although its ATP hydrolase activity can be activated artificially in vitro (By similarity). With the catalytic subunit beta (ATP5F1B), forms the catalytic core in the F(1) domain (PubMed:37244256). Subunit alpha does not bear the catalytic high-affinity ATP-binding sites (Probable). Binds the bacterial siderophore enterobactin and can promote mitochondrial accumulation of enterobactin-derived iron ions (PubMed:30146159). {ECO:0000250|UniProtKB:P19483, ECO:0000269|PubMed:30146159, ECO:0000269|PubMed:37244256, ECO:0000305|PubMed:37244256}. |
P37231 | PPARG | S273 | psp | Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) | Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated pro-inflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of BMAL1 in the blood vessels (By similarity). {ECO:0000250|UniProtKB:P37238, ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:9065481}.; FUNCTION: (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein. {ECO:0000269|PubMed:25504154}. |
P38432 | COIL | S202 | psp | Coilin (p80-coilin) | Component of nuclear coiled bodies, also known as Cajal bodies or CBs, which are involved in the modification and assembly of nucleoplasmic snRNPs. {ECO:0000269|PubMed:7679389}. |
P49450 | CENPA | S68 | psp | Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A) | Histone H3-like nucleosomal protein that is specifically found in centromeric nucleosomes (PubMed:11756469, PubMed:14667408, PubMed:15282608, PubMed:15475964, PubMed:15702419, PubMed:17651496, PubMed:19114591, PubMed:20739937, PubMed:27499292, PubMed:7962047, PubMed:9024683). Replaces conventional H3 in the nucleosome core of centromeric chromatin that serves as an assembly site for the inner kinetochore (PubMed:18072184). The presence of CENPA subtly modifies the nucleosome structure and the way DNA is wrapped around the nucleosome and gives rise to protruding DNA ends that are less well-ordered and rigid compared to nucleosomes containing histone H3 (PubMed:26878239, PubMed:27499292). May serve as an epigenetic mark that propagates centromere identity through replication and cell division (PubMed:15282608, PubMed:15475964, PubMed:20739937, PubMed:21478274, PubMed:26878239). Required for recruitment and assembly of kinetochore proteins, and as a consequence required for progress through mitosis, chromosome segregation and cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18072184, PubMed:23818633, PubMed:25556658, PubMed:27499292). {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419, ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184, ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:21478274, ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683, ECO:0000305|PubMed:20739937}. |
P49792 | RANBP2 | T1992 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P49796 | RGS3 | S1044 | ochoa | Regulator of G-protein signaling 3 (RGP3) (RGS3) | Down-regulates signaling from heterotrimeric G-proteins by increasing the GTPase activity of the alpha subunits, thereby driving them into their inactive GDP-bound form. Down-regulates G-protein-mediated release of inositol phosphates and activation of MAP kinases. {ECO:0000269|PubMed:10749886, ECO:0000269|PubMed:11294858, ECO:0000269|PubMed:8602223, ECO:0000269|PubMed:9858594}. |
P49959 | MRE11 | S676 | ochoa|psp | Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A) | Core component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed:11741547, PubMed:14657032, PubMed:22078559, PubMed:23080121, PubMed:24316220, PubMed:26240375, PubMed:27889449, PubMed:28867292, PubMed:29670289, PubMed:30464262, PubMed:30612738, PubMed:31353207, PubMed:37696958, PubMed:38128537, PubMed:9590181, PubMed:9651580, PubMed:9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S and G2 phases (PubMed:24316220, PubMed:28867292, PubMed:31353207, PubMed:38128537). The complex (1) mediates the end resection of damaged DNA, which generates proper single-stranded DNA, a key initial steps in HR, and is (2) required for the recruitment of other repair factors and efficient activation of ATM and ATR upon DNA damage (PubMed:24316220, PubMed:27889449, PubMed:28867292, PubMed:36050397, PubMed:38128537). Within the MRN complex, MRE11 possesses both single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity (PubMed:11741547, PubMed:22078559, PubMed:24316220, PubMed:26240375, PubMed:27889449, PubMed:29670289, PubMed:31353207, PubMed:36563124, PubMed:9590181, PubMed:9651580, PubMed:9705271). After DSBs, MRE11 is loaded onto DSBs sites and cleaves DNA by cooperating with RBBP8/CtIP to initiate end resection (PubMed:27814491, PubMed:27889449, PubMed:30787182). MRE11 first endonucleolytically cleaves the 5' strand at DNA DSB ends to prevent non-homologous end joining (NHEJ) and licence HR (PubMed:24316220). It then generates a single-stranded DNA gap via 3' to 5' exonucleolytic degradation to create entry sites for EXO1- and DNA2-mediated 5' to 3' long-range resection, which is required for single-strand invasion and recombination (PubMed:24316220, PubMed:28867292). RBBP8/CtIP specifically promotes the endonuclease activity of MRE11 to clear protein-DNA adducts and generate clean double-strand break ends (PubMed:27814491, PubMed:27889449, PubMed:30787182). MRE11 endonuclease activity is also enhanced by AGER/RAGE (By similarity). The MRN complex is also required for DNA damage signaling via activation of the ATM and ATR kinases: the nuclease activity of MRE11 is not required to activate ATM and ATR (PubMed:14657032, PubMed:15064416, PubMed:15790808, PubMed:16622404). The MRN complex is also required for the processing of R-loops (PubMed:31537797). The MRN complex is involved in the activation of the cGAS-STING pathway induced by DNA damage during tumorigenesis: the MRN complex acts by displacing CGAS from nucleosome sequestration, thereby activating it (By similarity). In telomeres the MRN complex may modulate t-loop formation (PubMed:10888888). {ECO:0000250|UniProtKB:Q61216, ECO:0000269|PubMed:10888888, ECO:0000269|PubMed:11741547, ECO:0000269|PubMed:14657032, ECO:0000269|PubMed:15064416, ECO:0000269|PubMed:15790808, ECO:0000269|PubMed:16622404, ECO:0000269|PubMed:22078559, ECO:0000269|PubMed:23080121, ECO:0000269|PubMed:24316220, ECO:0000269|PubMed:26240375, ECO:0000269|PubMed:27814491, ECO:0000269|PubMed:27889449, ECO:0000269|PubMed:28867292, ECO:0000269|PubMed:29670289, ECO:0000269|PubMed:30464262, ECO:0000269|PubMed:30612738, ECO:0000269|PubMed:30787182, ECO:0000269|PubMed:31353207, ECO:0000269|PubMed:31537797, ECO:0000269|PubMed:36050397, ECO:0000269|PubMed:36563124, ECO:0000269|PubMed:37696958, ECO:0000269|PubMed:38128537, ECO:0000269|PubMed:9590181, ECO:0000269|PubMed:9651580, ECO:0000269|PubMed:9705271}.; FUNCTION: MRE11 contains two DNA-binding domains (DBDs), enabling it to bind both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). {ECO:0000305}. |
P50461 | CSRP3 | S153 | ochoa | Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein) | Positive regulator of myogenesis. Acts as a cofactor for myogenic bHLH transcription factors such as MYOD1, and probably MYOG and MYF6. Enhances the DNA-binding activity of the MYOD1:TCF3 isoform E47 complex and may promote formation of a functional MYOD1:TCF3 isoform E47:MEF2A complex involved in myogenesis (By similarity). Plays a crucial and specific role in the organization of cytosolic structures in cardiomyocytes. Could play a role in mechanical stretch sensing. May be a scaffold protein that promotes the assembly of interacting proteins at Z-line structures. It is essential for calcineurin anchorage to the Z line. Required for stress-induced calcineurin-NFAT activation (By similarity). The role in regulation of cytoskeleton dynamics by association with CFL2 is reported conflictingly: Shown to enhance CFL2-mediated F-actin depolymerization dependent on the CSRP3:CFL2 molecular ratio, and also shown to reduce the ability of CLF1 and CFL2 to enhance actin depolymerization (PubMed:19752190, PubMed:24934443). Proposed to contribute to the maintenance of muscle cell integrity through an actin-based mechanism. Can directly bind to actin filaments, cross-link actin filaments into bundles without polarity selectivity and protect them from dilution- and cofilin-mediated depolymerization; the function seems to involve its self-association (PubMed:24934443). In vitro can inhibit PKC/PRKCA activity (PubMed:27353086). Proposed to be involved in cardiac stress signaling by down-regulating excessive PKC/PRKCA signaling (By similarity). {ECO:0000250|UniProtKB:P50462, ECO:0000250|UniProtKB:P50463, ECO:0000269|PubMed:19752190, ECO:0000269|PubMed:24934443, ECO:0000269|PubMed:27353086}.; FUNCTION: [Isoform 2]: May play a role in early sarcomere organization. Overexpression in myotubes negatively regulates myotube differentiation. By association with isoform 1 and thus changing the CSRP3 isoform 1:CFL2 stoichiometry is proposed to down-regulate CFL2-mediated F-actin depolymerization. {ECO:0000269|PubMed:24860983}. |
P56211 | ARPP19 | S46 | psp | cAMP-regulated phosphoprotein 19 (ARPP-19) | Protein phosphatase inhibitor that specifically inhibits protein phosphatase 2A (PP2A) during mitosis (PubMed:38123684). Inhibition of PP2A is enhanced when ARPP19 is phosphorylated (PubMed:38123684). When phosphorylated at Ser-62 during mitosis, specifically interacts with PPP2R2D (PR55-delta) and inhibits its activity, leading to inactivation of PP2A, an essential condition to keep cyclin-B1-CDK1 activity high during M phase (PubMed:21164014). May indirectly enhance GAP-43 expression (By similarity). {ECO:0000250|UniProtKB:Q712U5, ECO:0000269|PubMed:21164014, ECO:0000269|PubMed:38123684}. |
P63165 | SUMO1 | S31 | ochoa | Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1) | Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1 (PubMed:19223394). Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 (PubMed:24651376). {ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:18538659, ECO:0000269|PubMed:19223394, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24651376, ECO:0000269|PubMed:9019411, ECO:0000269|PubMed:9162015}. |
Q00872 | MYBPC1 | S295 | ochoa | Myosin-binding protein C, slow-type (Slow MyBP-C) (C-protein, skeletal muscle slow isoform) | Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. Slow skeletal protein that binds to both myosin and actin (PubMed:31025394, PubMed:31264822). In vitro, binds to native thin filaments and modifies the activity of actin-activated myosin ATPase. May modulate muscle contraction or may play a more structural role. {ECO:0000269|PubMed:31025394, ECO:0000269|PubMed:31264822}. |
Q01804 | OTUD4 | S1011 | ochoa | OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1) | Deubiquitinase which hydrolyzes the isopeptide bond between the ubiquitin C-terminus and the lysine epsilon-amino group of the target protein (PubMed:23827681, PubMed:25944111, PubMed:29395066). May negatively regulate inflammatory and pathogen recognition signaling in innate immune response. Upon phosphorylation at Ser-202 and Ser-204 residues, via IL-1 receptor and Toll-like receptor signaling pathway, specifically deubiquitinates 'Lys-63'-polyubiquitinated MYD88 adapter protein triggering down-regulation of NF-kappa-B-dependent transcription of inflammatory mediators (PubMed:29395066). Independently of the catalytic activity, acts as a scaffold for alternative deubiquitinases to assemble specific deubiquitinase-substrate complexes. Associates with USP7 and USP9X deubiquitinases to stabilize alkylation repair enzyme ALKBH3, thereby promoting the repair of alkylated DNA lesions (PubMed:25944111). {ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:25944111, ECO:0000269|PubMed:29395066}. |
Q09666 | AHNAK | S4516 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S4986 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q12872 | SFSWAP | S273 | ochoa | Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog) | Plays a role as an alternative splicing regulator. Regulate its own expression at the level of RNA processing. Also regulates the splicing of fibronectin and CD45 genes. May act, at least in part, by interaction with other R/S-containing splicing factors. Represses the splicing of MAPT/Tau exon 10. {ECO:0000269|PubMed:8940107}. |
Q12986 | NFX1 | S123 | ochoa | Transcriptional repressor NF-X1 (EC 2.3.2.-) (Nuclear transcription factor, X box-binding protein 1) | Binds to the X-box motif of MHC class II genes and represses their expression. May play an important role in regulating the duration of an inflammatory response by limiting the period in which MHC class II molecules are induced by interferon-gamma. Isoform 3 binds to the X-box motif of TERT promoter and represses its expression. Together with PABPC1 or PABPC4, isoform 1 acts as a coactivator for TERT expression. Mediates E2-dependent ubiquitination. {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:15371341, ECO:0000269|PubMed:17267499}. |
Q13428 | TCOF1 | S1378 | ochoa | Treacle protein (Treacher Collins syndrome protein) | Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:12777385, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with NOLC1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). {ECO:0000269|PubMed:12777385, ECO:0000269|PubMed:26399832}. |
Q13523 | PRP4K | S623 | ochoa | Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog) | Serine/threonine kinase involved in spliceosomal assembly as well as mitosis and signaling regulation (PubMed:10799319, PubMed:12077342, PubMed:17513757, PubMed:17998396). Connects chromatin mediated regulation of transcription and pre-mRNA splicing (PubMed:12077342). During spliceosomal assembly, interacts with and phosphorylates PRPF6 and PRPF31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), to facilitate the formation of the spliceosome B complex. Plays a role in regulating transcription and the spindle assembly checkpoint (SAC) (PubMed:20118938). Associates with U5 snRNP and NCOR1 deacetylase complexes which may allow a coordination of pre-mRNA splicing with chromatin remodeling events involved in transcriptional regulation (PubMed:12077342). Associates and probably phosphorylates SMARCA4 and NCOR1 (PubMed:12077342). Phosphorylates SRSF1 (PubMed:11418604). Associates with kinetochores during mitosis and is necessary for recruitment and maintenance of the checkpoint proteins such as MAD1L1 and MAD12L1 at the kinetochores (PubMed:17998396). Phosphorylates and regulates the activity of the transcription factors such as ELK1 and KLF13 (PubMed:10799319, PubMed:17513757). Phosphorylates nuclear YAP1 and WWTR1/TAZ which induces nuclear exclusion and regulates Hippo signaling pathway, involved in tissue growth control (PubMed:29695716). {ECO:0000269|PubMed:10799319, ECO:0000269|PubMed:11418604, ECO:0000269|PubMed:12077342, ECO:0000269|PubMed:17513757, ECO:0000269|PubMed:17998396, ECO:0000269|PubMed:20118938, ECO:0000269|PubMed:29695716}. |
Q13642 | FHL1 | S98 | ochoa | Four and a half LIM domains protein 1 (FHL-1) (Skeletal muscle LIM-protein 1) (SLIM) (SLIM-1) | May have an involvement in muscle development or hypertrophy. |
Q14590 | ZNF235 | S249 | ochoa | Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6) | May be involved in transcriptional regulation. |
Q14872 | MTF1 | S609 | ochoa | Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) | Zinc-dependent transcriptional regulator of cellular adaption to conditions of exposure to heavy metals (PubMed:8065932). Binds to metal responsive elements (MRE) in promoters and activates the transcription of metallothionein genes like metallothionein-2/MT2A (PubMed:8065932). Also regulates the expression of metalloproteases in response to intracellular zinc and functions as a catabolic regulator of cartilages (By similarity). {ECO:0000250|UniProtKB:Q07243, ECO:0000269|PubMed:8065932}. |
Q15111 | PLCL1 | S95 | ochoa | Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP) | Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C. {ECO:0000250, ECO:0000269|PubMed:17254016}. |
Q16637 | SMN1 | S88 | ochoa|psp | Survival motor neuron protein (Component of gems 1) (Gemin-1) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs (PubMed:18984161, PubMed:9845364). Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core) (PubMed:18984161). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP (PubMed:18984161). To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate (PubMed:18984161). Within the SMN complex, SMN1 acts as a structural backbone and together with GEMIN2 it gathers the Sm complex subunits (PubMed:17178713, PubMed:21816274, PubMed:22101937). Binding of snRNA inside 5Sm ultimately triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP (PubMed:31799625). Ensures the correct splicing of U12 intron-containing genes that may be important for normal motor and proprioceptive neurons development (PubMed:23063131). Also required for resolving RNA-DNA hybrids created by RNA polymerase II, that form R-loop in transcription terminal regions, an important step in proper transcription termination (PubMed:26700805). May also play a role in the metabolism of small nucleolar ribonucleoprotein (snoRNPs). {ECO:0000269|PubMed:17178713, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21816274, ECO:0000269|PubMed:22101937, ECO:0000269|PubMed:23063131, ECO:0000269|PubMed:26700805, ECO:0000269|PubMed:31799625, ECO:0000269|PubMed:9845364}. |
Q19T08 | ECSCR | S165 | ochoa | Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2) | Regulates endothelial chemotaxis and tube formation. Has a role in angiogenesis and apoptosis via modulation of the actin cytoskeleton and facilitation of proteasomal degradation of the apoptosis inhibitors BIRC3/IAP1 and BIRC2/IAP2. {ECO:0000269|PubMed:18556573, ECO:0000269|PubMed:19416853}. |
Q562F6 | SGO2 | S1138 | ochoa | Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin) | Cooperates with PPP2CA to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I. Has a crucial role in protecting REC8 at centromeres from cleavage by separase. During meiosis, protects centromeric cohesion complexes until metaphase II/anaphase II transition, preventing premature release of meiosis-specific REC8 cohesin complexes from anaphase I centromeres. Is thus essential for an accurate gametogenesis. May act by targeting PPP2CA to centromeres, thus leading to cohesin dephosphorylation (By similarity). Essential for recruiting KIF2C to the inner centromere and for correcting defective kinetochore attachments. Involved in centromeric enrichment of AUKRB in prometaphase. {ECO:0000250, ECO:0000269|PubMed:16541025, ECO:0000269|PubMed:17485487, ECO:0000269|PubMed:20739936}. |
Q5FBB7 | SGO1 | S436 | ochoa | Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1) | Plays a central role in chromosome cohesion during mitosis by preventing premature dissociation of cohesin complex from centromeres after prophase, when most of cohesin complex dissociates from chromosomes arms. May act by preventing phosphorylation of the STAG2 subunit of cohesin complex at the centromere, ensuring cohesin persistence at centromere until cohesin cleavage by ESPL1/separase at anaphase. Essential for proper chromosome segregation during mitosis and this function requires interaction with PPP2R1A. Its phosphorylated form is necessary for chromosome congression and for the proper attachment of spindle microtubule to the kinetochore. Necessary for kinetochore localization of PLK1 and CENPF. May play a role in the tension sensing mechanism of the spindle-assembly checkpoint by regulating PLK1 kinetochore affinity. Isoform 3 plays a role in maintaining centriole cohesion involved in controlling spindle pole integrity. Involved in centromeric enrichment of AUKRB in prometaphase. {ECO:0000269|PubMed:15604152, ECO:0000269|PubMed:15723797, ECO:0000269|PubMed:15737064, ECO:0000269|PubMed:16580887, ECO:0000269|PubMed:17617734, ECO:0000269|PubMed:17621308, ECO:0000269|PubMed:18331714, ECO:0000269|PubMed:20739936}. |
Q5JPF3 | ANKRD36C | S512 | ochoa | Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies) | None |
Q5SVZ6 | ZMYM1 | S944 | ochoa | Zinc finger MYM-type protein 1 | None |
Q5TAP6 | UTP14C | S98 | ochoa | U3 small nucleolar RNA-associated protein 14 homolog C | Essential for spermatogenesis. May be required specifically for ribosome biogenesis and hence protein synthesis during male meiosis (By similarity). {ECO:0000250, ECO:0000269|PubMed:15289605}. |
Q5VYS8 | TUT7 | S724 | ochoa | Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6) | Uridylyltransferase that mediates the terminal uridylation of mRNAs with short (less than 25 nucleotides) poly(A) tails, hence facilitating global mRNA decay (PubMed:19703396, PubMed:25480299). Essential for both oocyte maturation and fertility. Through 3' terminal uridylation of mRNA, sculpts, with TUT7, the maternal transcriptome by eliminating transcripts during oocyte growth (By similarity). Involved in microRNA (miRNA)-induced gene silencing through uridylation of deadenylated miRNA targets (PubMed:25480299). Also functions as an integral regulator of microRNA biogenesiS using 3 different uridylation mechanisms (PubMed:25979828). Acts as a suppressor of miRNA biogenesis by mediating the terminal uridylation of some miRNA precursors, including that of let-7 (pre-let-7). Uridylated pre-let-7 RNA is not processed by Dicer and undergo degradation. Pre-let-7 uridylation is strongly enhanced in the presence of LIN28A (PubMed:22898984). In the absence of LIN28A, TUT7 and TUT4 monouridylate group II pre-miRNAs, which includes most of pre-let7 members, that shapes an optimal 3' end overhang for efficient processing (PubMed:25979828, PubMed:28671666). Add oligo-U tails to truncated pre-miRNAS with a 5' overhang which may promote rapid degradation of non-functional pre-miRNA species (PubMed:25979828). Does not play a role in replication-dependent histone mRNA degradation (PubMed:18172165). Due to functional redundancy between TUT4 and TUT7, the identification of the specific role of each of these proteins is difficult (PubMed:18172165, PubMed:19703396, PubMed:22898984, PubMed:25480299, PubMed:25979828, PubMed:28671666). TUT4 and TUT7 restrict retrotransposition of long interspersed element-1 (LINE-1) in cooperation with MOV10 counteracting the RNA chaperonne activity of L1RE1. TUT7 uridylates LINE-1 mRNAs in the cytoplasm which inhibits initiation of reverse transcription once in the nucleus, whereas uridylation by TUT4 destabilizes mRNAs in cytoplasmic ribonucleoprotein granules (PubMed:30122351). {ECO:0000250|UniProtKB:Q5BLK4, ECO:0000269|PubMed:18172165, ECO:0000269|PubMed:19703396, ECO:0000269|PubMed:22898984, ECO:0000269|PubMed:25480299, ECO:0000269|PubMed:25979828, ECO:0000269|PubMed:28671666, ECO:0000269|PubMed:30122351}. |
Q68DQ2 | CRYBG3 | S912 | ochoa | Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3) | [Isoform vlAKAP]: Anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA). {ECO:0000269|PubMed:25097019}. |
Q6DD88 | ATL3 | S38 | ochoa | Atlastin-3 (AT3) (ATL-3) (EC 3.6.5.-) | Atlastin-3 (ATL3) is a membrane-anchored GTPase that mediates the GTP-dependent fusion of endoplasmic reticulum (ER) membranes, maintaining the continuous ER network. It facilitates the formation of three-way junctions where ER tubules intersect (PubMed:18270207, PubMed:19665976, PubMed:24459106, PubMed:27619977, PubMed:37102997). Two atlastin-3 on neighboring ER tubules bind GTP and form loose homodimers through the GB1/RHD3-type G domains and 3HB regions. Upon GTP hydrolysis, the 3HB regions tighten, pulling the membranes together to drive their fusion. After fusion, the homodimer disassembles upon release of inorganic phosphate (Pi). Subsequently, GDP dissociates, resetting the monomers to a conformation ready for a new fusion cycle (By similarity). {ECO:0000250|UniProtKB:Q8WXF7, ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:19665976, ECO:0000269|PubMed:24459106, ECO:0000269|PubMed:27619977, ECO:0000269|PubMed:37102997}. |
Q6KC79 | NIPBL | S1736 | ochoa | Nipped-B-like protein (Delangin) (SCC2 homolog) | Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin (PubMed:22628566, PubMed:28914604). Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed:28167679). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (By similarity). {ECO:0000250|UniProtKB:Q6KCD5, ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:28167679, ECO:0000269|PubMed:28914604}. |
Q6UB98 | ANKRD12 | S568 | ochoa | Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein) | May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation. |
Q709C8 | VPS13C | S3641 | ochoa | Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C) | Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Necessary for proper mitochondrial function and maintenance of mitochondrial transmembrane potential (PubMed:26942284). Involved in the regulation of PINK1/PRKN-mediated mitophagy in response to mitochondrial depolarization (PubMed:26942284). {ECO:0000250|UniProtKB:Q07878, ECO:0000269|PubMed:26942284}. |
Q7L4I2 | RSRC2 | S348 | ochoa | Arginine/serine-rich coiled-coil protein 2 | None |
Q7Z2E3 | APTX | S182 | ochoa | Aprataxin (EC 3.6.1.71) (EC 3.6.1.72) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT) | DNA-binding protein involved in single-strand DNA break repair, double-strand DNA break repair and base excision repair (PubMed:15044383, PubMed:15380105, PubMed:16964241, PubMed:17276982, PubMed:24362567). Resolves abortive DNA ligation intermediates formed either at base excision sites, or when DNA ligases attempt to repair non-ligatable breaks induced by reactive oxygen species (PubMed:16964241, PubMed:24362567). Catalyzes the release of adenylate groups covalently linked to 5'-phosphate termini, resulting in the production of 5'-phosphate termini that can be efficiently rejoined (PubMed:16964241, PubMed:17276982, PubMed:24362567). Also able to hydrolyze adenosine 5'-monophosphoramidate (AMP-NH(2)) and diadenosine tetraphosphate (AppppA), but with lower catalytic activity (PubMed:16547001). Likewise, catalyzes the release of 3'-linked guanosine (DNAppG) and inosine (DNAppI) from DNA, but has higher specific activity with 5'-linked adenosine (AppDNA) (By similarity). {ECO:0000250|UniProtKB:O74859, ECO:0000269|PubMed:15044383, ECO:0000269|PubMed:15380105, ECO:0000269|PubMed:16547001, ECO:0000269|PubMed:16964241, ECO:0000269|PubMed:17276982, ECO:0000269|PubMed:24362567}. |
Q7Z3J3 | RGPD4 | T1017 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q7Z5J4 | RAI1 | S636 | ochoa | Retinoic acid-induced protein 1 | Transcriptional regulator of the circadian clock components: CLOCK, BMAL1, BMAL2, PER1/3, CRY1/2, NR1D1/2 and RORA/C. Positively regulates the transcriptional activity of CLOCK a core component of the circadian clock. Regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. May be important for embryonic and postnatal development. May be involved in neuronal differentiation. {ECO:0000269|PubMed:22578325}. |
Q7Z6M1 | RABEPK | S61 | ochoa | Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40) | Rab9 effector required for endosome to trans-Golgi network (TGN) transport. {ECO:0000269|PubMed:9230071}. |
Q86V48 | LUZP1 | S518 | ochoa | Leucine zipper protein 1 (Filamin mechanobinding actin cross-linking protein) (Fimbacin) | F-actin cross-linking protein (PubMed:30990684). Stabilizes actin and acts as a negative regulator of primary cilium formation (PubMed:32496561). Positively regulates the phosphorylation of both myosin II and protein phosphatase 1 regulatory subunit PPP1R12A/MYPT1 and promotes the assembly of myosin II stacks within actin stress fibers (PubMed:38832964). Inhibits the phosphorylation of myosin light chain MYL9 by DAPK3 and suppresses the constriction velocity of the contractile ring during cytokinesis (PubMed:38009294). Binds to microtubules and promotes epithelial cell apical constriction by up-regulating levels of diphosphorylated myosin light chain (MLC) through microtubule-dependent inhibition of MLC dephosphorylation by myosin phosphatase (By similarity). Involved in regulation of cell migration, nuclear size and centriole number, probably through regulation of the actin cytoskeleton (By similarity). Component of the CERF-1 and CERF-5 chromatin remodeling complexes in embryonic stem cells where it acts to stabilize the complexes (By similarity). Plays a role in embryonic brain and cardiovascular development (By similarity). {ECO:0000250|UniProtKB:Q8R4U7, ECO:0000269|PubMed:30990684, ECO:0000269|PubMed:32496561, ECO:0000269|PubMed:38009294, ECO:0000269|PubMed:38832964}. |
Q8IVF2 | AHNAK2 | S3408 | ochoa | Protein AHNAK2 | None |
Q8IYB5 | SMAP1 | S207 | ochoa | Stromal membrane-associated protein 1 | GTPase activating protein that acts on ARF6. Plays a role in clathrin-dependent endocytosis. May play a role in erythropoiesis (By similarity). {ECO:0000250}. |
Q8N556 | AFAP1 | S548 | ochoa | Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110) | Can cross-link actin filaments into both network and bundle structures (By similarity). May modulate changes in actin filament integrity and induce lamellipodia formation. May function as an adapter molecule that links other proteins, such as SRC and PKC to the actin cytoskeleton. Seems to play a role in the development and progression of prostate adenocarcinoma by regulating cell-matrix adhesions and migration in the cancer cells. {ECO:0000250, ECO:0000269|PubMed:15485829}. |
Q8TBZ3 | WDR20 | S491 | ochoa | WD repeat-containing protein 20 (Protein DMR) | Regulator of deubiquitinating complexes. Activates deubiquitinating activity of complexes containing USP12 (PubMed:20147737, PubMed:27373336). Anchors at the base of the ubiquitin-contacting loop of USP12 and remotely modulates the catalytic center of the enzyme (PubMed:27373336). Regulates shuttling of the USP12 deubiquitinase complex between the plasma membrane, cytoplasm and nucleus (PubMed:30466959). {ECO:0000269|PubMed:20147737, ECO:0000269|PubMed:27373336, ECO:0000269|PubMed:30466959}. |
Q8TF68 | ZNF384 | S269 | ochoa | Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein) | Transcription factor that binds the consensus DNA sequence [GC]AAAAA. Seems to bind and regulate the promoters of MMP1, MMP3, MMP7 and COL1A1 (By similarity). {ECO:0000250}. |
Q92576 | PHF3 | S283 | ochoa | PHD finger protein 3 | None |
Q93073 | SECISBP2L | S934 | ochoa | Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like) | Binds SECIS (Sec insertion sequence) elements present on selenocysteine (Sec) protein mRNAs, but does not promote Sec incorporation into selenoproteins in vitro. |
Q96C57 | CUSTOS | S214 | ochoa | Protein CUSTOS | Plays a role in the regulation of Wnt signaling pathway during early development. {ECO:0000250|UniProtKB:A9C3N6}. |
Q96JQ2 | CLMN | S619 | ochoa | Calmin (Calponin-like transmembrane domain protein) | None |
Q99666 | RGPD5 | T1016 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q9BQF6 | SENP7 | S92 | ochoa | Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) | Protease that acts as a positive regulator of the cGAS-STING pathway by catalyzing desumoylation of CGAS. Desumoylation of CGAS promotes DNA-binding activity of CGAS, subsequent oligomerization and activation (By similarity). Deconjugates SUMO2 and SUMO3 from targeted proteins, but not SUMO1 (PubMed:18799455). Catalyzes the deconjugation of poly-SUMO2 and poly-SUMO3 chains (PubMed:18799455). Has very low efficiency in processing full-length SUMO proteins to their mature forms (PubMed:18799455). {ECO:0000250|UniProtKB:Q8BUH8, ECO:0000269|PubMed:18799455}. |
Q9BVJ6 | UTP14A | S99 | ochoa | U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16) | May be required for ribosome biogenesis. {ECO:0000250}. |
Q9BXW9 | FANCD2 | S337 | ochoa | Fanconi anemia group D2 protein (Protein FACD2) | Required for maintenance of chromosomal stability (PubMed:11239453, PubMed:14517836). Promotes accurate and efficient pairing of homologs during meiosis (PubMed:14517836). Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing (PubMed:15671039, PubMed:15650050, PubMed:30335751, PubMed:36385258). The FANCI-FANCD2 complex binds and scans double-stranded DNA (dsDNA) for DNA damage; this complex stalls at DNA junctions between double-stranded DNA and single-stranded DNA (By similarity). May participate in S phase and G2 phase checkpoint activation upon DNA damage (PubMed:15377654). Plays a role in preventing breakage and loss of missegregating chromatin at the end of cell division, particularly after replication stress (PubMed:15454491, PubMed:15661754). Required for the targeting, or stabilization, of BLM to non-centromeric abnormal structures induced by replicative stress (PubMed:15661754, PubMed:19465921). Promotes BRCA2/FANCD1 loading onto damaged chromatin (PubMed:11239454, PubMed:12239151, PubMed:12086603, PubMed:15115758, PubMed:15199141, PubMed:15671039, PubMed:18212739). May also be involved in B-cell immunoglobulin isotype switching. {ECO:0000250|UniProtKB:Q68Y81, ECO:0000269|PubMed:11239453, ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836, ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022, ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491, ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921, ECO:0000269|PubMed:30335751, ECO:0000269|PubMed:36385258}. |
Q9BZI7 | UPF3B | S412 | ochoa | Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X) | Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons by associating with the nuclear exon junction complex (EJC) and serving as link between the EJC core and NMD machinery. Recruits UPF2 at the cytoplasmic side of the nuclear envelope and the subsequent formation of an UPF1-UPF2-UPF3 surveillance complex (including UPF1 bound to release factors at the stalled ribosome) is believed to activate NMD. In cooperation with UPF2 stimulates both ATPase and RNA helicase activities of UPF1. Binds spliced mRNA upstream of exon-exon junctions. In vitro, stimulates translation; the function is independent of association with UPF2 and components of the EJC core. {ECO:0000269|PubMed:11163187, ECO:0000269|PubMed:12718880, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:16601204, ECO:0000269|PubMed:18066079}. |
Q9C0C9 | UBE2O | S399 | ochoa | (E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O) | E2/E3 hybrid ubiquitin-protein ligase that displays both E2 and E3 ligase activities and mediates monoubiquitination of target proteins (PubMed:23455153, PubMed:24703950). Negatively regulates TRAF6-mediated NF-kappa-B activation independently of its E2 activity (PubMed:23381138). Acts as a positive regulator of BMP7 signaling by mediating monoubiquitination of SMAD6, thereby regulating adipogenesis (PubMed:23455153). Mediates monoubiquitination at different sites of the nuclear localization signal (NLS) of BAP1, leading to cytoplasmic retention of BAP1. Also able to monoubiquitinate the NLS of other chromatin-associated proteins, such as INO80 and CXXC1, affecting their subcellular location (PubMed:24703950). Acts as a regulator of retrograde transport by assisting the TRIM27:MAGEL2 E3 ubiquitin ligase complex to mediate 'Lys-63'-linked ubiquitination of WASHC1, leading to promote endosomal F-actin assembly (PubMed:23452853). {ECO:0000269|PubMed:23381138, ECO:0000269|PubMed:23452853, ECO:0000269|PubMed:23455153, ECO:0000269|PubMed:24703950}. |
Q9H4L7 | SMARCAD1 | S173 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (SMARCAD1) (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1) | DNA helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity and is both required for DNA repair and heterochromatin organization. Promotes DNA end resection of double-strand breaks (DSBs) following DNA damage: probably acts by weakening histone DNA interactions in nucleosomes flanking DSBs. Required for the restoration of heterochromatin organization after replication. Acts at replication sites to facilitate the maintenance of heterochromatin by directing H3 and H4 histones deacetylation, H3 'Lys-9' trimethylation (H3K9me3) and restoration of silencing. {ECO:0000269|PubMed:21549307, ECO:0000269|PubMed:22960744}. |
Q9H799 | CPLANE1 | S3073 | ochoa | Ciliogenesis and planar polarity effector 1 (Protein JBTS17) | Involved in ciliogenesis (PubMed:25877302, PubMed:35582950). Involved in the establishment of cell polarity required for directional cell migration. Proposed to act in association with the CPLANE (ciliogenesis and planar polarity effectors) complex. Involved in recruitment of peripheral IFT-A proteins to basal bodies (By similarity). {ECO:0000250|UniProtKB:Q8CE72, ECO:0000269|PubMed:35582950, ECO:0000305|PubMed:25877302}. |
Q9P2E9 | RRBP1 | S533 | ochoa | Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein) | Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}. |
Q9P2E9 | RRBP1 | S583 | ochoa | Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein) | Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}. |
Q9UJM3 | ERRFI1 | S390 | ochoa | ERBB receptor feedback inhibitor 1 (Mitogen-inducible gene 6 protein) (MIG-6) | Negative regulator of EGFR signaling in skin morphogenesis. Acts as a negative regulator for several EGFR family members, including ERBB2, ERBB3 and ERBB4. Inhibits EGFR catalytic activity by interfering with its dimerization. Inhibits autophosphorylation of EGFR, ERBB2 and ERBB4. Important for normal keratinocyte proliferation and differentiation. Plays a role in modulating the response to steroid hormones in the uterus. Required for normal response to progesterone in the uterus and for fertility. Mediates epithelial estrogen responses in the uterus by regulating ESR1 levels and activation. Important for regulation of endometrium cell proliferation. Important for normal prenatal and perinatal lung development (By similarity). {ECO:0000250}. |
Q9UJU6 | DBNL | S146 | ochoa | Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7) | Adapter protein that binds F-actin and DNM1, and thereby plays a role in receptor-mediated endocytosis. Plays a role in the reorganization of the actin cytoskeleton, formation of cell projections, such as neurites, in neuron morphogenesis and synapse formation via its interaction with WASL and COBL. Does not bind G-actin and promote actin polymerization by itself. Required for the formation of organized podosome rosettes (By similarity). May act as a common effector of antigen receptor-signaling pathways in leukocytes. Acts as a key component of the immunological synapse that regulates T-cell activation by bridging TCRs and the actin cytoskeleton to gene activation and endocytic processes. {ECO:0000250, ECO:0000269|PubMed:14729663}. |
Q9UKJ3 | GPATCH8 | S1065 | ochoa | G patch domain-containing protein 8 | None |
Q9UKK9 | NUDT5 | T45 | ochoa | ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H) | Enzyme that can either act as an ADP-sugar pyrophosphatase in absence of diphosphate or catalyze the synthesis of ATP in presence of diphosphate (PubMed:27257257). In absence of diphosphate, hydrolyzes with similar activities various modified nucleoside diphosphates such as ADP-ribose, ADP-mannose, ADP-glucose, 8-oxo-GDP and 8-oxo-dGDP (PubMed:10567213, PubMed:10722730, PubMed:17052728, PubMed:19699693, PubMed:21389046). Can also hydrolyze other nucleotide sugars with low activity (PubMed:19699693, PubMed:21389046). In presence of diphosphate, mediates the synthesis of ATP in the nucleus by catalyzing the conversion of ADP-ribose to ATP and ribose 5-phosphate. Nuclear ATP synthesis takes place when dephosphorylated at Thr-45 (PubMed:27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming (PubMed:27257257). Does not play a role in U8 snoRNA decapping activity (By similarity). Binds U8 snoRNA (By similarity). {ECO:0000250|UniProtKB:Q9JKX6, ECO:0000269|PubMed:10567213, ECO:0000269|PubMed:10722730, ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:19699693, ECO:0000269|PubMed:21389046, ECO:0000269|PubMed:27257257}. |
Q9UMD9 | COL17A1 | S384 | ochoa | Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)] | May play a role in the integrity of hemidesmosome and the attachment of basal keratinocytes to the underlying basement membrane.; FUNCTION: The 120 kDa linear IgA disease antigen is an anchoring filament component involved in dermal-epidermal cohesion. Is the target of linear IgA bullous dermatosis autoantibodies. |
Q9UMY1 | NOL7 | S133 | ochoa | U3 small nucleolar RNA-associated protein NOL7 (U3 snoRNA-associated protein NOL7) (Nucleolar protein 7) (Nucleolar protein of 27 kDa) | Functions as part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit that coordinates the first two steps of ribosome biogenesis in transcription of the primary transcript pre-RNA and pre-18S processing (PubMed:34516797, PubMed:37246770). During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). This subunit is required for processing of the 5'-external transcribed spacer sequence (5'ETS) of the primary transcript pre-rRNA to yield the 18S rRNA (PubMed:37246770). Also plays a role in maintaining early pre-rRNA levels, either by assisting in its transcription or stability (PubMed:37246770). {ECO:0000269|PubMed:34516797, ECO:0000269|PubMed:37246770}. |
Q9Y2H2 | INPP5F | S123 | ochoa | Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2) | Inositol 4-phosphatase which mainly acts on phosphatidylinositol 4-phosphate. May be functionally linked to OCRL, which converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol, for a sequential dephosphorylation of phosphatidylinositol 4,5-bisphosphate at the 5 and 4 position of inositol, thus playing an important role in the endocytic recycling (PubMed:25869669). Regulator of TF:TFRC and integrins recycling pathway, is also involved in cell migration mechanisms (PubMed:25869669). Modulates AKT/GSK3B pathway by decreasing AKT and GSK3B phosphorylation (PubMed:17322895). Negatively regulates STAT3 signaling pathway through inhibition of STAT3 phosphorylation and translocation to the nucleus (PubMed:25476455). Functionally important modulator of cardiac myocyte size and of the cardiac response to stress (By similarity). May play a role as negative regulator of axon regeneration after central nervous system injuries (By similarity). {ECO:0000250|UniProtKB:Q8CDA1, ECO:0000269|PubMed:17322895, ECO:0000269|PubMed:25476455, ECO:0000269|PubMed:25869669}. |
Q9Y2I8 | WDR37 | S136 | ochoa | WD repeat-containing protein 37 | Required for normal ER Ca2+ handling in lymphocytes. Together with PACS1, it plays an essential role in stabilizing peripheral lymphocyte populations. {ECO:0000250|UniProtKB:Q8CBE3}. |
Q9Y2M0 | FAN1 | S180 | ochoa | Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (hFAN1) (Myotubularin-related protein 15) | Nuclease required for the repair of DNA interstrand cross-links (ICL) recruited at sites of DNA damage by monoubiquitinated FANCD2. Specifically involved in repair of ICL-induced DNA breaks by being required for efficient homologous recombination, probably in the resolution of homologous recombination intermediates (PubMed:20603015, PubMed:20603016, PubMed:20603073, PubMed:20671156, PubMed:24981866, PubMed:25430771). Not involved in DNA double-strand breaks resection (PubMed:20603015, PubMed:20603016). Acts as a 5'-3' exonuclease that anchors at a cut end of DNA and cleaves DNA successively at every third nucleotide, allowing to excise an ICL from one strand through flanking incisions. Probably keeps excising with 3'-flap annealing until it reaches and unhooks the ICL (PubMed:25430771). Acts at sites that have a 5'-terminal phosphate anchor at a nick or a 1- or 2-nucleotide flap and is augmented by a 3' flap (PubMed:25430771). Also has endonuclease activity toward 5'-flaps (PubMed:20603015, PubMed:20603016, PubMed:24981866). {ECO:0000269|PubMed:20603015, ECO:0000269|PubMed:20603016, ECO:0000269|PubMed:20603073, ECO:0000269|PubMed:20671156, ECO:0000269|PubMed:24981866, ECO:0000269|PubMed:25135477, ECO:0000269|PubMed:25430771}. |
P24752 | ACAT1 | S218 | Sugiyama | Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2) | This is one of the enzymes that catalyzes the last step of the mitochondrial beta-oxidation pathway, an aerobic process breaking down fatty acids into acetyl-CoA (PubMed:1715688, PubMed:7728148, PubMed:9744475). Using free coenzyme A/CoA, catalyzes the thiolytic cleavage of medium- to long-chain 3-oxoacyl-CoAs into acetyl-CoA and a fatty acyl-CoA shortened by two carbon atoms (PubMed:1715688, PubMed:7728148, PubMed:9744475). The activity of the enzyme is reversible and it can also catalyze the condensation of two acetyl-CoA molecules into acetoacetyl-CoA (PubMed:17371050). Thereby, it plays a major role in ketone body metabolism (PubMed:1715688, PubMed:17371050, PubMed:7728148, PubMed:9744475). {ECO:0000269|PubMed:1715688, ECO:0000269|PubMed:17371050, ECO:0000269|PubMed:7728148, ECO:0000269|PubMed:9744475}. |
P25208 | NFYB | S95 | Sugiyama | Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB) | Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors. |
Q9NP74 | PALMD | S194 | Sugiyama | Palmdelphin (Paralemmin-like protein) | None |
P48506 | GCLC | S215 | Sugiyama | Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase) | Catalyzes the ATP-dependent ligation of L-glutamate and L-cysteine and participates in the first and rate-limiting step in glutathione biosynthesis. {ECO:0000269|PubMed:9675072}. |
Q14204 | DYNC1H1 | S3257 | Sugiyama | Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) | Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression (PubMed:27462074). {ECO:0000269|PubMed:27462074}. |
O95835 | LATS1 | S593 | Sugiyama | Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts) | Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:10518011, PubMed:10831611, PubMed:18158288, PubMed:26437443, PubMed:28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:18158288, PubMed:26437443, PubMed:28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:18158288, PubMed:26437443, PubMed:28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed:15122335, PubMed:19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed:9988268). Involved in the control of p53 expression (PubMed:15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed:15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed:28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:10831611, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15220930, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:39173637, ECO:0000269|PubMed:9988268}. |
P53621 | COPA | S730 | Sugiyama | Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] | The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.; FUNCTION: Xenin stimulates exocrine pancreatic secretion. It inhibits pentagastrin-stimulated secretion of acid, to induce exocrine pancreatic secretion and to affect small and large intestinal motility. In the gut, xenin interacts with the neurotensin receptor. |
P22314 | UBA1 | Y845 | Sugiyama | Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1) | Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1447181, PubMed:1606621, PubMed:33108101). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP (PubMed:1447181). Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites (PubMed:22456334). {ECO:0000269|PubMed:1447181, ECO:0000269|PubMed:1606621, ECO:0000269|PubMed:22456334, ECO:0000269|PubMed:33108101}. |
O75116 | ROCK2 | S724 | Sugiyama | Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) | Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation. {ECO:0000269|PubMed:10579722, ECO:0000269|PubMed:15699075, ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21147781}. |
P51451 | BLK | S190 | Sugiyama | Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) | Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling (By similarity). B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors (By similarity). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (By similarity). Signaling through BLK plays an important role in transmitting signals through surface immunoglobulins and supports the pro-B to pre-B transition, as well as the signaling for growth arrest and apoptosis downstream of B-cell receptor (By similarity). Specifically binds and phosphorylates CD79A at 'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-207' (By similarity). Also phosphorylates the immunoglobulin G receptors FCGR2A, FCGR2B and FCGR2C (PubMed:8756631). With FYN and LYN, plays an essential role in pre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation (By similarity). Also contributes to BTK activation by indirectly stimulating BTK intramolecular autophosphorylation (By similarity). In pancreatic islets, acts as a modulator of beta-cells function through the up-regulation of PDX1 and NKX6-1 and consequent stimulation of insulin secretion in response to glucose (PubMed:19667185). Phosphorylates CGAS, promoting retention of CGAS in the cytosol (PubMed:30356214). {ECO:0000250|UniProtKB:P16277, ECO:0000269|PubMed:19667185, ECO:0000269|PubMed:30356214, ECO:0000269|PubMed:8756631}. |
Q7KZI7 | MARK2 | S704 | Sugiyama | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q5T4S7 | UBR4 | S1723 | Sugiyama | E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) | E3 ubiquitin-protein ligase involved in different protein quality control pathways in the cytoplasm (PubMed:25582440, PubMed:29033132, PubMed:34893540, PubMed:37891180, PubMed:38030679, PubMed:38182926, PubMed:38297121). Component of the N-end rule pathway: ubiquitinates proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their degradation (PubMed:34893540, PubMed:37891180, PubMed:38030679). Recognizes both type-1 and type-2 N-degrons, containing positively charged amino acids (Arg, Lys and His) and bulky and hydrophobic amino acids, respectively (PubMed:38030679). Does not ubiquitinate proteins that are acetylated at the N-terminus (PubMed:37891180). Together with UBR5, part of a cytoplasm protein quality control pathway that prevents protein aggregation by catalyzing assembly of heterotypic 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on aggregated proteins, leading to substrate recognition by the segregase p97/VCP and degradation by the proteasome: UBR4 probably synthesizes mixed chains containing multiple linkages, while UBR5 is likely branching multiple 'Lys-48'-linked chains of substrates initially modified (PubMed:29033132). Together with KCMF1, part of a protein quality control pathway that catalyzes ubiquitination and degradation of proteins that have been oxidized in response to reactive oxygen species (ROS): recognizes proteins with an Arg-CysO3(H) degron at the N-terminus, and mediates assembly of heterotypic 'Lys-63'-/'Lys-27'-linked branched ubiquitin chains on oxidized proteins, leading to their degradation by autophagy (PubMed:34893540). Catalytic component of the SIFI complex, a multiprotein complex required to inhibit the mitochondrial stress response after a specific stress event has been resolved: ubiquitinates and degrades (1) components of the HRI-mediated signaling of the integrated stress response, such as DELE1 and EIF2AK1/HRI, as well as (2) unimported mitochondrial precursors (PubMed:38297121). Within the SIFI complex, UBR4 initiates ubiquitin chain that are further elongated or branched by KCMF1 (PubMed:38297121). Mediates ubiquitination of ACLY, leading to its subsequent degradation (PubMed:23932781). Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization (PubMed:16214886). {ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:23932781, ECO:0000269|PubMed:25582440, ECO:0000269|PubMed:29033132, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:37891180, ECO:0000269|PubMed:38030679, ECO:0000269|PubMed:38182926, ECO:0000269|PubMed:38297121}. |
Q9P0L2 | MARK1 | S711 | Sugiyama | Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2 and MAP4. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:17573348, ECO:0000269|PubMed:23666762}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.000007 | 5.185 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.000007 | 5.185 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.000019 | 4.723 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.000033 | 4.487 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.000065 | 4.190 |
R-HSA-68886 | M Phase | 0.000183 | 3.737 |
R-HSA-1433559 | Regulation of KIT signaling | 0.000330 | 3.481 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.000396 | 3.403 |
R-HSA-68882 | Mitotic Anaphase | 0.000352 | 3.453 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.000362 | 3.441 |
R-HSA-1640170 | Cell Cycle | 0.000864 | 3.063 |
R-HSA-68877 | Mitotic Prometaphase | 0.000964 | 3.016 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.001017 | 2.993 |
R-HSA-8939245 | RUNX1 regulates transcription of genes involved in BCR signaling | 0.001240 | 2.906 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.001214 | 2.916 |
R-HSA-9022707 | MECP2 regulates transcription factors | 0.002496 | 2.603 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 0.005049 | 2.297 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 0.005049 | 2.297 |
R-HSA-210990 | PECAM1 interactions | 0.004800 | 2.319 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.006317 | 2.199 |
R-HSA-5467333 | APC truncation mutants are not K63 polyubiquitinated | 0.007240 | 2.140 |
R-HSA-9915355 | Beta-ketothiolase deficiency | 0.021563 | 1.666 |
R-HSA-5578999 | Defective GCLC causes HAGGSD | 0.035682 | 1.448 |
R-HSA-5660489 | MTF1 activates gene expression | 0.042666 | 1.370 |
R-HSA-8869496 | TFAP2A acts as a transcriptional repressor during retinoic acid induced cell dif... | 0.063316 | 1.198 |
R-HSA-9027283 | Erythropoietin activates STAT5 | 0.063316 | 1.198 |
R-HSA-177539 | Autointegration results in viral DNA circles | 0.063316 | 1.198 |
R-HSA-114516 | Disinhibition of SNARE formation | 0.070101 | 1.154 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.083526 | 1.078 |
R-HSA-9027277 | Erythropoietin activates Phospholipase C gamma (PLCG) | 0.090166 | 1.045 |
R-HSA-4839744 | Signaling by APC mutants | 0.096758 | 1.014 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 0.096758 | 1.014 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 0.096758 | 1.014 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 0.096758 | 1.014 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 0.103302 | 0.986 |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 0.109800 | 0.959 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 0.109800 | 0.959 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 0.109800 | 0.959 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 0.109800 | 0.959 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 0.109800 | 0.959 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 0.109800 | 0.959 |
R-HSA-3928663 | EPHA-mediated growth cone collapse | 0.024390 | 1.613 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 0.116251 | 0.935 |
R-HSA-9027284 | Erythropoietin activates RAS | 0.129015 | 0.889 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 0.129015 | 0.889 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 0.141595 | 0.849 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.041195 | 1.385 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.160129 | 0.796 |
R-HSA-163210 | Formation of ATP by chemiosmotic coupling | 0.166219 | 0.779 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.166219 | 0.779 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.166219 | 0.779 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.166219 | 0.779 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.166219 | 0.779 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 0.172264 | 0.764 |
R-HSA-9938206 | Developmental Lineage of Mammary Stem Cells | 0.184226 | 0.735 |
R-HSA-202430 | Translocation of ZAP-70 to Immunological synapse | 0.196015 | 0.708 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 0.201847 | 0.695 |
R-HSA-191859 | snRNP Assembly | 0.085908 | 1.066 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.085908 | 1.066 |
R-HSA-9006335 | Signaling by Erythropoietin | 0.224756 | 0.648 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.224756 | 0.648 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.230380 | 0.638 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.235965 | 0.627 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.235965 | 0.627 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.247013 | 0.607 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.247013 | 0.607 |
R-HSA-390522 | Striated Muscle Contraction | 0.252477 | 0.598 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.252477 | 0.598 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.117797 | 0.929 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.263289 | 0.580 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.139623 | 0.855 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.284449 | 0.546 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.082687 | 1.083 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.082687 | 1.083 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.289644 | 0.538 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.082687 | 1.083 |
R-HSA-446107 | Type I hemidesmosome assembly | 0.076838 | 1.114 |
R-HSA-389359 | CD28 dependent Vav1 pathway | 0.116251 | 0.935 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.182852 | 0.738 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.057331 | 1.242 |
R-HSA-774815 | Nucleosome assembly | 0.057331 | 1.242 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.085908 | 1.066 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.103785 | 0.984 |
R-HSA-162592 | Integration of provirus | 0.103302 | 0.986 |
R-HSA-180746 | Nuclear import of Rev protein | 0.036271 | 1.440 |
R-HSA-202427 | Phosphorylation of CD3 and TCR zeta chains | 0.213384 | 0.671 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.224756 | 0.648 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.094723 | 1.024 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 0.103302 | 0.986 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 0.141595 | 0.849 |
R-HSA-416993 | Trafficking of GluR2-containing AMPA receptors | 0.153996 | 0.812 |
R-HSA-6783310 | Fanconi Anemia Pathway | 0.057331 | 1.242 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.247013 | 0.607 |
R-HSA-9670439 | Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT m... | 0.017975 | 1.745 |
R-HSA-9843745 | Adipogenesis | 0.022831 | 1.641 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.252477 | 0.598 |
R-HSA-381183 | ATF6 (ATF6-alpha) activates chaperone genes | 0.103302 | 0.986 |
R-HSA-2424491 | DAP12 signaling | 0.230380 | 0.638 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.037366 | 1.428 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.247013 | 0.607 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.182852 | 0.738 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.132250 | 0.879 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 0.166219 | 0.779 |
R-HSA-4791275 | Signaling by WNT in cancer | 0.241509 | 0.617 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 0.178267 | 0.749 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.257903 | 0.589 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.056494 | 1.248 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.070101 | 1.154 |
R-HSA-8866904 | Negative regulation of activity of TFAP2 (AP-2) family transcription factors | 0.076838 | 1.114 |
R-HSA-2465910 | MASTL Facilitates Mitotic Progression | 0.083526 | 1.078 |
R-HSA-4839748 | Signaling by AMER1 mutants | 0.103302 | 0.986 |
R-HSA-4839735 | Signaling by AXIN mutants | 0.103302 | 0.986 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.046355 | 1.334 |
R-HSA-8866652 | Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 0.213384 | 0.671 |
R-HSA-8949613 | Cristae formation | 0.213384 | 0.671 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 0.224756 | 0.648 |
R-HSA-399719 | Trafficking of AMPA receptors | 0.235965 | 0.627 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.257903 | 0.589 |
R-HSA-389356 | Co-stimulation by CD28 | 0.063126 | 1.200 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.056494 | 1.248 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.046355 | 1.334 |
R-HSA-9010642 | ROBO receptors bind AKAP5 | 0.076838 | 1.114 |
R-HSA-912631 | Regulation of signaling by CBL | 0.160129 | 0.796 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 0.217072 | 0.663 |
R-HSA-389513 | Co-inhibition by CTLA4 | 0.014533 | 1.838 |
R-HSA-5620922 | BBSome-mediated cargo-targeting to cilium | 0.166219 | 0.779 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.252477 | 0.598 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.279216 | 0.554 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.239563 | 0.621 |
R-HSA-175567 | Integration of viral DNA into host genomic DNA | 0.063316 | 1.198 |
R-HSA-2179392 | EGFR Transactivation by Gastrin | 0.090166 | 1.045 |
R-HSA-164843 | 2-LTR circle formation | 0.090166 | 1.045 |
R-HSA-77108 | Utilization of Ketone Bodies | 0.096758 | 1.014 |
R-HSA-180689 | APOBEC3G mediated resistance to HIV-1 infection | 0.103302 | 0.986 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.153996 | 0.812 |
R-HSA-5218921 | VEGFR2 mediated cell proliferation | 0.201847 | 0.695 |
R-HSA-9646399 | Aggrephagy | 0.289644 | 0.538 |
R-HSA-400685 | Sema4D in semaphorin signaling | 0.201847 | 0.695 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.081600 | 1.088 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.169919 | 0.770 |
R-HSA-381033 | ATF6 (ATF6-alpha) activates chaperones | 0.116251 | 0.935 |
R-HSA-2028269 | Signaling by Hippo | 0.147818 | 0.830 |
R-HSA-9837999 | Mitochondrial protein degradation | 0.175074 | 0.757 |
R-HSA-399997 | Acetylcholine regulates insulin secretion | 0.141595 | 0.849 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 0.213384 | 0.671 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.263289 | 0.580 |
R-HSA-9669938 | Signaling by KIT in disease | 0.017975 | 1.745 |
R-HSA-3928662 | EPHB-mediated forward signaling | 0.055444 | 1.256 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 0.172264 | 0.764 |
R-HSA-9706374 | FLT3 signaling through SRC family kinases | 0.042666 | 1.370 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.103302 | 0.986 |
R-HSA-9820865 | Z-decay: degradation of maternal mRNAs by zygotically expressed factors | 0.109800 | 0.959 |
R-HSA-877312 | Regulation of IFNG signaling | 0.109800 | 0.959 |
R-HSA-75892 | Platelet Adhesion to exposed collagen | 0.116251 | 0.935 |
R-HSA-429947 | Deadenylation of mRNA | 0.196015 | 0.708 |
R-HSA-9725554 | Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | 0.284449 | 0.546 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.213639 | 0.670 |
R-HSA-114604 | GPVI-mediated activation cascade | 0.039527 | 1.403 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.055444 | 1.256 |
R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK | 0.160129 | 0.796 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 0.213384 | 0.671 |
R-HSA-162909 | Host Interactions of HIV factors | 0.018624 | 1.730 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 0.247013 | 0.607 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 0.257903 | 0.589 |
R-HSA-164944 | Nef and signal transduction | 0.063316 | 1.198 |
R-HSA-167590 | Nef Mediated CD4 Down-regulation | 0.070101 | 1.154 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 0.129015 | 0.889 |
R-HSA-70350 | Fructose catabolism | 0.135328 | 0.869 |
R-HSA-5099900 | WNT5A-dependent internalization of FZD4 | 0.135328 | 0.869 |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | 0.153996 | 0.812 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.279216 | 0.554 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 0.289644 | 0.538 |
R-HSA-74182 | Ketone body metabolism | 0.190142 | 0.721 |
R-HSA-8953854 | Metabolism of RNA | 0.283637 | 0.547 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.025257 | 1.598 |
R-HSA-68875 | Mitotic Prophase | 0.074741 | 1.126 |
R-HSA-202433 | Generation of second messenger molecules | 0.289644 | 0.538 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 0.230380 | 0.638 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.284449 | 0.546 |
R-HSA-450520 | HuR (ELAVL1) binds and stabilizes mRNA | 0.083526 | 1.078 |
R-HSA-5652084 | Fructose metabolism | 0.184226 | 0.735 |
R-HSA-380994 | ATF4 activates genes in response to endoplasmic reticulum stress | 0.219090 | 0.659 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.273945 | 0.562 |
R-HSA-162906 | HIV Infection | 0.106349 | 0.973 |
R-HSA-5660526 | Response to metal ions | 0.141595 | 0.849 |
R-HSA-77111 | Synthesis of Ketone Bodies | 0.166219 | 0.779 |
R-HSA-71384 | Ethanol oxidation | 0.184226 | 0.735 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.094723 | 1.024 |
R-HSA-1989781 | PPARA activates gene expression | 0.132189 | 0.879 |
R-HSA-9683610 | Maturation of nucleoprotein | 0.116251 | 0.935 |
R-HSA-174403 | Glutathione synthesis and recycling | 0.178267 | 0.749 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.135468 | 0.868 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 0.083526 | 1.078 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 0.190142 | 0.721 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 0.207636 | 0.683 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.284449 | 0.546 |
R-HSA-9854311 | Maturation of TCA enzymes and regulation of TCA cycle | 0.289644 | 0.538 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.195714 | 0.708 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 0.196015 | 0.708 |
R-HSA-9865118 | Diseases of branched-chain amino acid catabolism | 0.207636 | 0.683 |
R-HSA-5365859 | RA biosynthesis pathway | 0.257903 | 0.589 |
R-HSA-381042 | PERK regulates gene expression | 0.263289 | 0.580 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.241088 | 0.618 |
R-HSA-111933 | Calmodulin induced events | 0.268636 | 0.571 |
R-HSA-111997 | CaM pathway | 0.268636 | 0.571 |
R-HSA-194138 | Signaling by VEGF | 0.270594 | 0.568 |
R-HSA-73886 | Chromosome Maintenance | 0.257173 | 0.590 |
R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane | 0.201847 | 0.695 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 0.172493 | 0.763 |
R-HSA-9833482 | PKR-mediated signaling | 0.134697 | 0.871 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 0.034684 | 1.460 |
R-HSA-9694631 | Maturation of nucleoprotein | 0.160129 | 0.796 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.184226 | 0.735 |
R-HSA-982772 | Growth hormone receptor signaling | 0.190142 | 0.721 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.273945 | 0.562 |
R-HSA-164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to cla... | 0.147818 | 0.830 |
R-HSA-3000170 | Syndecan interactions | 0.190142 | 0.721 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.263289 | 0.580 |
R-HSA-9819196 | Zygotic genome activation (ZGA) | 0.015645 | 1.806 |
R-HSA-2393930 | Phosphate bond hydrolysis by NUDT proteins | 0.257903 | 0.589 |
R-HSA-74160 | Gene expression (Transcription) | 0.193606 | 0.713 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.130559 | 0.884 |
R-HSA-9020558 | Interleukin-2 signaling | 0.096758 | 1.014 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.031596 | 1.500 |
R-HSA-1834941 | STING mediated induction of host immune responses | 0.160129 | 0.796 |
R-HSA-8964038 | LDL clearance | 0.184226 | 0.735 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.262541 | 0.581 |
R-HSA-8853659 | RET signaling | 0.268636 | 0.571 |
R-HSA-8948216 | Collagen chain trimerization | 0.273945 | 0.562 |
R-HSA-75153 | Apoptotic execution phase | 0.059241 | 1.227 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.247013 | 0.607 |
R-HSA-8964043 | Plasma lipoprotein clearance | 0.284449 | 0.546 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.164791 | 0.783 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.257173 | 0.590 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.279059 | 0.554 |
R-HSA-451927 | Interleukin-2 family signaling | 0.289644 | 0.538 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.292053 | 0.535 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.294801 | 0.530 |
R-HSA-9607240 | FLT3 Signaling | 0.294801 | 0.530 |
R-HSA-73894 | DNA Repair | 0.298745 | 0.525 |
R-HSA-9683701 | Translation of Structural Proteins | 0.299922 | 0.523 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 0.305006 | 0.516 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.305006 | 0.516 |
R-HSA-111996 | Ca-dependent events | 0.305006 | 0.516 |
R-HSA-2172127 | DAP12 interactions | 0.315063 | 0.502 |
R-HSA-69236 | G1 Phase | 0.315063 | 0.502 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.315063 | 0.502 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.320038 | 0.495 |
R-HSA-1489509 | DAG and IP3 signaling | 0.320038 | 0.495 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.324977 | 0.488 |
R-HSA-9675135 | Diseases of DNA repair | 0.324977 | 0.488 |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | 0.324977 | 0.488 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 0.329880 | 0.482 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.329880 | 0.482 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.334748 | 0.475 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.334748 | 0.475 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.337324 | 0.472 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.347866 | 0.459 |
R-HSA-912446 | Meiotic recombination | 0.349143 | 0.457 |
R-HSA-70895 | Branched-chain amino acid catabolism | 0.349143 | 0.457 |
R-HSA-2514856 | The phototransduction cascade | 0.349143 | 0.457 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.353117 | 0.452 |
R-HSA-72187 | mRNA 3'-end processing | 0.353872 | 0.451 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 0.353872 | 0.451 |
R-HSA-6794361 | Neurexins and neuroligins | 0.353872 | 0.451 |
R-HSA-212436 | Generic Transcription Pathway | 0.355532 | 0.449 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 0.358567 | 0.445 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.360446 | 0.443 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 0.363229 | 0.440 |
R-HSA-162587 | HIV Life Cycle | 0.363575 | 0.439 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.364378 | 0.438 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.366180 | 0.436 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 0.367856 | 0.434 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.367856 | 0.434 |
R-HSA-418597 | G alpha (z) signalling events | 0.367856 | 0.434 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.370320 | 0.431 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 0.372451 | 0.429 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.376232 | 0.425 |
R-HSA-109581 | Apoptosis | 0.376559 | 0.424 |
R-HSA-5621480 | Dectin-2 family | 0.377012 | 0.424 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.377012 | 0.424 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.386036 | 0.413 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 0.386036 | 0.413 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.390500 | 0.408 |
R-HSA-156590 | Glutathione conjugation | 0.390500 | 0.408 |
R-HSA-5362517 | Signaling by Retinoic Acid | 0.390500 | 0.408 |
R-HSA-1227986 | Signaling by ERBB2 | 0.390500 | 0.408 |
R-HSA-422475 | Axon guidance | 0.393487 | 0.405 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.394931 | 0.403 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.394931 | 0.403 |
R-HSA-112043 | PLC beta mediated events | 0.394931 | 0.403 |
R-HSA-1442490 | Collagen degradation | 0.394931 | 0.403 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.399330 | 0.399 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 0.399330 | 0.399 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.399330 | 0.399 |
R-HSA-1268020 | Mitochondrial protein import | 0.399330 | 0.399 |
R-HSA-9707616 | Heme signaling | 0.399330 | 0.399 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.399653 | 0.398 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.403698 | 0.394 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.403698 | 0.394 |
R-HSA-373755 | Semaphorin interactions | 0.403698 | 0.394 |
R-HSA-9679506 | SARS-CoV Infections | 0.407908 | 0.389 |
R-HSA-5690714 | CD22 mediated BCR regulation | 0.408034 | 0.389 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.412314 | 0.385 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.416612 | 0.380 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.420855 | 0.376 |
R-HSA-112040 | G-protein mediated events | 0.420855 | 0.376 |
R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 0.425067 | 0.372 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.425067 | 0.372 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.433401 | 0.363 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.433401 | 0.363 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 0.437523 | 0.359 |
R-HSA-453276 | Regulation of mitotic cell cycle | 0.437523 | 0.359 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.437523 | 0.359 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 0.437523 | 0.359 |
R-HSA-69275 | G2/M Transition | 0.439698 | 0.357 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 0.441615 | 0.355 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.441615 | 0.355 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 0.441615 | 0.355 |
R-HSA-74259 | Purine catabolism | 0.441615 | 0.355 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.444604 | 0.352 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.444604 | 0.352 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.445678 | 0.351 |
R-HSA-4086398 | Ca2+ pathway | 0.445678 | 0.351 |
R-HSA-9675108 | Nervous system development | 0.446603 | 0.350 |
R-HSA-5617833 | Cilium Assembly | 0.449486 | 0.347 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.449711 | 0.347 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.449851 | 0.347 |
R-HSA-380287 | Centrosome maturation | 0.453715 | 0.343 |
R-HSA-8852135 | Protein ubiquitination | 0.453715 | 0.343 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.453715 | 0.343 |
R-HSA-71403 | Citric acid cycle (TCA cycle) | 0.453715 | 0.343 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.453715 | 0.343 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.454344 | 0.343 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.459178 | 0.338 |
R-HSA-9694635 | Translation of Structural Proteins | 0.461637 | 0.336 |
R-HSA-9609690 | HCMV Early Events | 0.463987 | 0.333 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.465555 | 0.332 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.465555 | 0.332 |
R-HSA-4086400 | PCP/CE pathway | 0.465555 | 0.332 |
R-HSA-5579029 | Metabolic disorders of biological oxidation enzymes | 0.469445 | 0.328 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.473307 | 0.325 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.477141 | 0.321 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.478266 | 0.320 |
R-HSA-376176 | Signaling by ROBO receptors | 0.480623 | 0.318 |
R-HSA-72172 | mRNA Splicing | 0.485319 | 0.314 |
R-HSA-5357801 | Programmed Cell Death | 0.487657 | 0.312 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.488477 | 0.311 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 0.488477 | 0.311 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.490909 | 0.309 |
R-HSA-1500620 | Meiosis | 0.492202 | 0.308 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.492202 | 0.308 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.499570 | 0.301 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.503666 | 0.298 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.506833 | 0.295 |
R-HSA-9663891 | Selective autophagy | 0.506833 | 0.295 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.513991 | 0.289 |
R-HSA-202424 | Downstream TCR signaling | 0.513991 | 0.289 |
R-HSA-1280218 | Adaptive Immune System | 0.515704 | 0.288 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.524535 | 0.280 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 0.524535 | 0.280 |
R-HSA-2029481 | FCGR activation | 0.527999 | 0.277 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.531438 | 0.275 |
R-HSA-1474290 | Collagen formation | 0.531438 | 0.275 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.535208 | 0.271 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.539579 | 0.268 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 0.541606 | 0.266 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 0.541606 | 0.266 |
R-HSA-72312 | rRNA processing | 0.548236 | 0.261 |
R-HSA-422356 | Regulation of insulin secretion | 0.548264 | 0.261 |
R-HSA-9614085 | FOXO-mediated transcription | 0.551556 | 0.258 |
R-HSA-70171 | Glycolysis | 0.554825 | 0.256 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.558898 | 0.253 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.561292 | 0.251 |
R-HSA-1483255 | PI Metabolism | 0.561292 | 0.251 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.564892 | 0.248 |
R-HSA-913531 | Interferon Signaling | 0.564892 | 0.248 |
R-HSA-111885 | Opioid Signalling | 0.567666 | 0.246 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.573948 | 0.241 |
R-HSA-1266738 | Developmental Biology | 0.575744 | 0.240 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.577055 | 0.239 |
R-HSA-211000 | Gene Silencing by RNA | 0.580139 | 0.236 |
R-HSA-9609646 | HCMV Infection | 0.585784 | 0.232 |
R-HSA-202403 | TCR signaling | 0.589259 | 0.230 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.595230 | 0.225 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.595230 | 0.225 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.595230 | 0.225 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.595230 | 0.225 |
R-HSA-5688426 | Deubiquitination | 0.595802 | 0.225 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.597784 | 0.223 |
R-HSA-9824446 | Viral Infection Pathways | 0.600181 | 0.222 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.601115 | 0.221 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.609783 | 0.215 |
R-HSA-9734767 | Developmental Cell Lineages | 0.611455 | 0.214 |
R-HSA-373760 | L1CAM interactions | 0.612631 | 0.213 |
R-HSA-416476 | G alpha (q) signalling events | 0.613380 | 0.212 |
R-HSA-70326 | Glucose metabolism | 0.615458 | 0.211 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.615458 | 0.211 |
R-HSA-8953897 | Cellular responses to stimuli | 0.617986 | 0.209 |
R-HSA-5693538 | Homology Directed Repair | 0.618265 | 0.209 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.618265 | 0.209 |
R-HSA-9711123 | Cellular response to chemical stress | 0.621005 | 0.207 |
R-HSA-3371556 | Cellular response to heat stress | 0.626564 | 0.203 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.631997 | 0.199 |
R-HSA-2132295 | MHC class II antigen presentation | 0.631997 | 0.199 |
R-HSA-2262752 | Cellular responses to stress | 0.635549 | 0.197 |
R-HSA-9664323 | FCGR3A-mediated IL10 synthesis | 0.642628 | 0.192 |
R-HSA-69481 | G2/M Checkpoints | 0.645238 | 0.190 |
R-HSA-8956319 | Nucleotide catabolism | 0.650402 | 0.187 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.652956 | 0.185 |
R-HSA-1474165 | Reproduction | 0.655491 | 0.183 |
R-HSA-9909396 | Circadian clock | 0.660506 | 0.180 |
R-HSA-1474228 | Degradation of the extracellular matrix | 0.660506 | 0.180 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.662987 | 0.178 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.669485 | 0.174 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.672730 | 0.172 |
R-HSA-163685 | Integration of energy metabolism | 0.672730 | 0.172 |
R-HSA-195721 | Signaling by WNT | 0.674554 | 0.171 |
R-HSA-6798695 | Neutrophil degranulation | 0.678285 | 0.169 |
R-HSA-6807070 | PTEN Regulation | 0.679854 | 0.168 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 0.679854 | 0.168 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.680600 | 0.167 |
R-HSA-9664407 | Parasite infection | 0.682195 | 0.166 |
R-HSA-9664417 | Leishmania phagocytosis | 0.682195 | 0.166 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.682195 | 0.166 |
R-HSA-1632852 | Macroautophagy | 0.684518 | 0.165 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.689114 | 0.162 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.689114 | 0.162 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.689749 | 0.161 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.693644 | 0.159 |
R-HSA-449147 | Signaling by Interleukins | 0.694788 | 0.158 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.698109 | 0.156 |
R-HSA-2187338 | Visual phototransduction | 0.700317 | 0.155 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.706845 | 0.151 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.711119 | 0.148 |
R-HSA-9609507 | Protein localization | 0.713232 | 0.147 |
R-HSA-8957322 | Metabolism of steroids | 0.715900 | 0.145 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.717414 | 0.144 |
R-HSA-9612973 | Autophagy | 0.719482 | 0.143 |
R-HSA-9610379 | HCMV Late Events | 0.721535 | 0.142 |
R-HSA-877300 | Interferon gamma signaling | 0.725596 | 0.139 |
R-HSA-1474244 | Extracellular matrix organization | 0.726259 | 0.139 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.727605 | 0.138 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.740507 | 0.130 |
R-HSA-5619102 | SLC transporter disorders | 0.741262 | 0.130 |
R-HSA-72306 | tRNA processing | 0.748760 | 0.126 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.750600 | 0.125 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.754241 | 0.122 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.754241 | 0.122 |
R-HSA-5689880 | Ub-specific processing proteases | 0.754241 | 0.122 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.756041 | 0.121 |
R-HSA-168255 | Influenza Infection | 0.764850 | 0.116 |
R-HSA-2559583 | Cellular Senescence | 0.766573 | 0.115 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.771669 | 0.113 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.798530 | 0.098 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.802933 | 0.095 |
R-HSA-397014 | Muscle contraction | 0.816934 | 0.088 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.816934 | 0.088 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.818279 | 0.087 |
R-HSA-418594 | G alpha (i) signalling events | 0.820575 | 0.086 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.835186 | 0.078 |
R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 0.838508 | 0.076 |
R-HSA-5668914 | Diseases of metabolism | 0.839814 | 0.076 |
R-HSA-15869 | Metabolism of nucleotides | 0.846640 | 0.072 |
R-HSA-156580 | Phase II - Conjugation of compounds | 0.850000 | 0.071 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.858607 | 0.066 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.863642 | 0.064 |
R-HSA-199991 | Membrane Trafficking | 0.868616 | 0.061 |
R-HSA-597592 | Post-translational protein modification | 0.871923 | 0.060 |
R-HSA-112316 | Neuronal System | 0.873572 | 0.059 |
R-HSA-5663205 | Infectious disease | 0.885402 | 0.053 |
R-HSA-446728 | Cell junction organization | 0.887575 | 0.052 |
R-HSA-211945 | Phase I - Functionalization of compounds | 0.887575 | 0.052 |
R-HSA-9658195 | Leishmania infection | 0.890045 | 0.051 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.890045 | 0.051 |
R-HSA-1483257 | Phospholipid metabolism | 0.900876 | 0.045 |
R-HSA-211859 | Biological oxidations | 0.908685 | 0.042 |
R-HSA-1500931 | Cell-Cell communication | 0.915171 | 0.038 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.919465 | 0.036 |
R-HSA-168256 | Immune System | 0.926039 | 0.033 |
R-HSA-388396 | GPCR downstream signalling | 0.932105 | 0.031 |
R-HSA-168249 | Innate Immune System | 0.933772 | 0.030 |
R-HSA-109582 | Hemostasis | 0.935694 | 0.029 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.940179 | 0.027 |
R-HSA-5653656 | Vesicle-mediated transport | 0.943612 | 0.025 |
R-HSA-162582 | Signal Transduction | 0.946676 | 0.024 |
R-HSA-372790 | Signaling by GPCR | 0.957069 | 0.019 |
R-HSA-1643685 | Disease | 0.965530 | 0.015 |
R-HSA-392499 | Metabolism of proteins | 0.973877 | 0.011 |
R-HSA-556833 | Metabolism of lipids | 0.987785 | 0.005 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.991239 | 0.004 |
R-HSA-382551 | Transport of small molecules | 0.999456 | 0.000 |
R-HSA-9709957 | Sensory Perception | 0.999926 | 0.000 |
R-HSA-1430728 | Metabolism | 0.999974 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CLK3 |
0.855 | 0.375 | 1 | 0.854 |
CDK18 |
0.850 | 0.490 | 1 | 0.846 |
NLK |
0.849 | 0.400 | 1 | 0.894 |
CDK7 |
0.848 | 0.451 | 1 | 0.883 |
CDK17 |
0.846 | 0.483 | 1 | 0.827 |
CDK5 |
0.846 | 0.462 | 1 | 0.880 |
MST4 |
0.846 | 0.220 | 2 | 0.853 |
SRPK1 |
0.844 | 0.229 | -3 | 0.718 |
CDK16 |
0.844 | 0.506 | 1 | 0.831 |
CDK8 |
0.844 | 0.422 | 1 | 0.874 |
COT |
0.843 | 0.031 | 2 | 0.792 |
HIPK4 |
0.841 | 0.271 | 1 | 0.832 |
KIS |
0.841 | 0.389 | 1 | 0.881 |
CDK1 |
0.840 | 0.447 | 1 | 0.865 |
P38G |
0.840 | 0.468 | 1 | 0.823 |
CDK3 |
0.840 | 0.451 | 1 | 0.833 |
JNK2 |
0.840 | 0.471 | 1 | 0.869 |
P38A |
0.840 | 0.445 | 1 | 0.864 |
NDR2 |
0.839 | 0.125 | -3 | 0.821 |
HIPK2 |
0.839 | 0.432 | 1 | 0.833 |
CDK19 |
0.839 | 0.420 | 1 | 0.858 |
MTOR |
0.839 | 0.101 | 1 | 0.792 |
NUAK2 |
0.839 | 0.146 | -3 | 0.825 |
CLK1 |
0.839 | 0.309 | -3 | 0.747 |
WNK1 |
0.839 | 0.151 | -2 | 0.886 |
PKN3 |
0.838 | 0.100 | -3 | 0.791 |
CDKL1 |
0.838 | 0.112 | -3 | 0.751 |
PRKD2 |
0.838 | 0.161 | -3 | 0.776 |
PRKD1 |
0.838 | 0.122 | -3 | 0.806 |
HIPK1 |
0.837 | 0.401 | 1 | 0.865 |
CDK13 |
0.837 | 0.414 | 1 | 0.875 |
CAMK1B |
0.837 | 0.085 | -3 | 0.832 |
ERK1 |
0.837 | 0.435 | 1 | 0.843 |
CDK9 |
0.837 | 0.429 | 1 | 0.878 |
CDKL5 |
0.837 | 0.131 | -3 | 0.748 |
ICK |
0.836 | 0.220 | -3 | 0.794 |
PRPK |
0.836 | -0.056 | -1 | 0.854 |
ERK5 |
0.836 | 0.174 | 1 | 0.781 |
PKCD |
0.836 | 0.153 | 2 | 0.755 |
CDK2 |
0.836 | 0.372 | 1 | 0.882 |
TSSK1 |
0.835 | 0.187 | -3 | 0.862 |
CDK10 |
0.835 | 0.466 | 1 | 0.867 |
DYRK2 |
0.835 | 0.378 | 1 | 0.861 |
P38B |
0.835 | 0.438 | 1 | 0.839 |
SRPK2 |
0.835 | 0.186 | -3 | 0.634 |
AMPKA1 |
0.835 | 0.137 | -3 | 0.842 |
CDK14 |
0.834 | 0.450 | 1 | 0.872 |
PKN2 |
0.834 | 0.122 | -3 | 0.822 |
NIK |
0.834 | 0.130 | -3 | 0.849 |
TBK1 |
0.834 | -0.044 | 1 | 0.676 |
CLK4 |
0.833 | 0.253 | -3 | 0.749 |
NDR1 |
0.833 | 0.101 | -3 | 0.815 |
CDK12 |
0.833 | 0.418 | 1 | 0.867 |
PIM3 |
0.833 | 0.038 | -3 | 0.802 |
PIM1 |
0.832 | 0.128 | -3 | 0.759 |
MOS |
0.832 | -0.003 | 1 | 0.746 |
RAF1 |
0.832 | -0.060 | 1 | 0.737 |
JNK3 |
0.832 | 0.429 | 1 | 0.882 |
CDC7 |
0.832 | -0.038 | 1 | 0.720 |
ERK2 |
0.831 | 0.417 | 1 | 0.865 |
TSSK2 |
0.830 | 0.127 | -5 | 0.810 |
DYRK1A |
0.829 | 0.325 | 1 | 0.895 |
AMPKA2 |
0.829 | 0.124 | -3 | 0.817 |
HIPK3 |
0.829 | 0.361 | 1 | 0.862 |
PDHK4 |
0.829 | -0.163 | 1 | 0.770 |
LATS2 |
0.828 | 0.072 | -5 | 0.731 |
BMPR2 |
0.828 | -0.145 | -2 | 0.901 |
ULK2 |
0.828 | -0.104 | 2 | 0.706 |
RSK2 |
0.827 | 0.064 | -3 | 0.751 |
MARK4 |
0.827 | 0.049 | 4 | 0.858 |
DSTYK |
0.827 | -0.076 | 2 | 0.829 |
NEK6 |
0.827 | -0.017 | -2 | 0.889 |
SKMLCK |
0.826 | 0.039 | -2 | 0.856 |
PRKD3 |
0.826 | 0.105 | -3 | 0.740 |
P70S6KB |
0.826 | 0.075 | -3 | 0.773 |
ATR |
0.826 | -0.032 | 1 | 0.744 |
PKCB |
0.826 | 0.137 | 2 | 0.726 |
NUAK1 |
0.826 | 0.083 | -3 | 0.781 |
CAMLCK |
0.826 | 0.016 | -2 | 0.840 |
DAPK2 |
0.826 | 0.024 | -3 | 0.830 |
MNK2 |
0.826 | 0.111 | -2 | 0.789 |
CLK2 |
0.826 | 0.270 | -3 | 0.737 |
DYRK1B |
0.825 | 0.384 | 1 | 0.865 |
TGFBR2 |
0.825 | -0.018 | -2 | 0.805 |
PHKG1 |
0.825 | 0.090 | -3 | 0.813 |
CAMK2G |
0.825 | -0.076 | 2 | 0.737 |
IKKE |
0.825 | -0.104 | 1 | 0.675 |
MELK |
0.825 | 0.105 | -3 | 0.803 |
CAMK2D |
0.825 | 0.013 | -3 | 0.812 |
PKCA |
0.825 | 0.113 | 2 | 0.721 |
MAPKAPK3 |
0.824 | 0.053 | -3 | 0.765 |
PDHK1 |
0.824 | -0.146 | 1 | 0.750 |
P38D |
0.824 | 0.428 | 1 | 0.834 |
GCN2 |
0.824 | -0.165 | 2 | 0.719 |
RIPK3 |
0.824 | -0.040 | 3 | 0.717 |
SRPK3 |
0.824 | 0.120 | -3 | 0.671 |
PKACG |
0.824 | 0.070 | -2 | 0.749 |
P90RSK |
0.823 | 0.032 | -3 | 0.743 |
RSK3 |
0.823 | 0.034 | -3 | 0.738 |
PKCG |
0.823 | 0.106 | 2 | 0.718 |
CDK6 |
0.823 | 0.424 | 1 | 0.861 |
WNK3 |
0.823 | -0.074 | 1 | 0.710 |
AURC |
0.823 | 0.092 | -2 | 0.632 |
LATS1 |
0.822 | 0.095 | -3 | 0.821 |
DYRK4 |
0.821 | 0.382 | 1 | 0.852 |
MLK1 |
0.821 | -0.078 | 2 | 0.786 |
NEK7 |
0.821 | -0.120 | -3 | 0.761 |
CHAK2 |
0.821 | -0.001 | -1 | 0.882 |
PKR |
0.821 | 0.069 | 1 | 0.711 |
MLK2 |
0.821 | -0.014 | 2 | 0.764 |
PRP4 |
0.821 | 0.252 | -3 | 0.757 |
IKKB |
0.820 | -0.155 | -2 | 0.778 |
CDK4 |
0.820 | 0.427 | 1 | 0.860 |
MNK1 |
0.820 | 0.130 | -2 | 0.799 |
HUNK |
0.820 | -0.087 | 2 | 0.699 |
NEK9 |
0.820 | -0.075 | 2 | 0.781 |
SSTK |
0.819 | 0.175 | 4 | 0.863 |
SGK3 |
0.819 | 0.091 | -3 | 0.753 |
BCKDK |
0.818 | -0.066 | -1 | 0.820 |
IRE1 |
0.818 | -0.013 | 1 | 0.656 |
PKCH |
0.818 | 0.084 | 2 | 0.703 |
NIM1 |
0.818 | 0.008 | 3 | 0.747 |
ANKRD3 |
0.818 | -0.081 | 1 | 0.745 |
QIK |
0.817 | 0.026 | -3 | 0.810 |
PKCZ |
0.817 | 0.070 | 2 | 0.730 |
CAMK2B |
0.817 | 0.048 | 2 | 0.723 |
MAPKAPK2 |
0.817 | 0.051 | -3 | 0.717 |
PHKG2 |
0.817 | 0.116 | -3 | 0.813 |
IRE2 |
0.817 | 0.009 | 2 | 0.695 |
ULK1 |
0.817 | -0.147 | -3 | 0.743 |
CAMK4 |
0.816 | 0.005 | -3 | 0.811 |
MLK3 |
0.816 | 0.005 | 2 | 0.733 |
SIK |
0.816 | 0.063 | -3 | 0.746 |
PKG2 |
0.815 | 0.075 | -2 | 0.676 |
DNAPK |
0.815 | 0.044 | 1 | 0.704 |
MASTL |
0.815 | -0.180 | -2 | 0.836 |
DCAMKL1 |
0.815 | 0.121 | -3 | 0.794 |
NEK2 |
0.815 | -0.015 | 2 | 0.757 |
QSK |
0.815 | 0.041 | 4 | 0.839 |
BRSK2 |
0.814 | 0.042 | -3 | 0.810 |
CAMK2A |
0.814 | 0.045 | 2 | 0.723 |
BRSK1 |
0.814 | 0.053 | -3 | 0.779 |
AKT2 |
0.814 | 0.073 | -3 | 0.676 |
PKACB |
0.814 | 0.078 | -2 | 0.666 |
DYRK3 |
0.813 | 0.261 | 1 | 0.852 |
CHK1 |
0.813 | 0.052 | -3 | 0.810 |
GRK5 |
0.813 | -0.184 | -3 | 0.790 |
DLK |
0.813 | -0.167 | 1 | 0.724 |
YSK4 |
0.813 | -0.064 | 1 | 0.690 |
RIPK1 |
0.813 | -0.145 | 1 | 0.697 |
MST3 |
0.812 | 0.124 | 2 | 0.800 |
AURB |
0.812 | 0.035 | -2 | 0.627 |
MARK3 |
0.812 | 0.064 | 4 | 0.804 |
PIM2 |
0.812 | 0.068 | -3 | 0.728 |
PAK1 |
0.812 | -0.002 | -2 | 0.759 |
PAK6 |
0.812 | 0.062 | -2 | 0.662 |
IKKA |
0.812 | -0.088 | -2 | 0.778 |
ALK4 |
0.811 | -0.035 | -2 | 0.842 |
RSK4 |
0.811 | 0.052 | -3 | 0.722 |
PAK3 |
0.811 | -0.031 | -2 | 0.762 |
ATM |
0.811 | -0.033 | 1 | 0.695 |
ERK7 |
0.811 | 0.160 | 2 | 0.539 |
CAMK1G |
0.810 | 0.047 | -3 | 0.733 |
MYLK4 |
0.810 | 0.012 | -2 | 0.755 |
VRK2 |
0.809 | -0.090 | 1 | 0.770 |
BMPR1B |
0.809 | 0.019 | 1 | 0.658 |
FAM20C |
0.809 | 0.083 | 2 | 0.632 |
DCAMKL2 |
0.809 | 0.076 | -3 | 0.818 |
MARK2 |
0.809 | 0.029 | 4 | 0.768 |
TGFBR1 |
0.809 | -0.019 | -2 | 0.822 |
PRKX |
0.808 | 0.122 | -3 | 0.699 |
PKCT |
0.808 | 0.061 | 2 | 0.711 |
TAO3 |
0.808 | 0.083 | 1 | 0.725 |
MAK |
0.808 | 0.287 | -2 | 0.732 |
CHAK1 |
0.808 | -0.052 | 2 | 0.689 |
MSK2 |
0.808 | -0.040 | -3 | 0.698 |
WNK4 |
0.808 | 0.006 | -2 | 0.869 |
PLK1 |
0.807 | -0.091 | -2 | 0.836 |
JNK1 |
0.807 | 0.360 | 1 | 0.862 |
PLK4 |
0.807 | -0.036 | 2 | 0.538 |
IRAK4 |
0.807 | 0.012 | 1 | 0.657 |
MEK1 |
0.807 | -0.157 | 2 | 0.740 |
MARK1 |
0.807 | 0.027 | 4 | 0.832 |
TTBK2 |
0.805 | -0.191 | 2 | 0.617 |
MOK |
0.805 | 0.269 | 1 | 0.799 |
GRK6 |
0.805 | -0.154 | 1 | 0.718 |
AKT1 |
0.805 | 0.059 | -3 | 0.704 |
DRAK1 |
0.804 | -0.033 | 1 | 0.711 |
PKCE |
0.804 | 0.118 | 2 | 0.711 |
TAO2 |
0.804 | 0.084 | 2 | 0.801 |
MEKK1 |
0.804 | -0.088 | 1 | 0.707 |
SMMLCK |
0.804 | 0.008 | -3 | 0.788 |
HRI |
0.804 | -0.102 | -2 | 0.875 |
NEK5 |
0.804 | -0.027 | 1 | 0.701 |
MSK1 |
0.803 | -0.017 | -3 | 0.711 |
PKCI |
0.803 | 0.064 | 2 | 0.715 |
CAMK1D |
0.802 | 0.071 | -3 | 0.692 |
MLK4 |
0.802 | -0.095 | 2 | 0.691 |
GRK1 |
0.802 | -0.095 | -2 | 0.771 |
MPSK1 |
0.802 | 0.044 | 1 | 0.661 |
PAK2 |
0.802 | -0.067 | -2 | 0.737 |
TLK2 |
0.801 | -0.109 | 1 | 0.687 |
ZAK |
0.801 | -0.098 | 1 | 0.688 |
SMG1 |
0.801 | -0.077 | 1 | 0.703 |
SNRK |
0.801 | -0.095 | 2 | 0.605 |
GRK7 |
0.800 | -0.045 | 1 | 0.685 |
PKN1 |
0.800 | 0.059 | -3 | 0.709 |
ALK2 |
0.800 | -0.049 | -2 | 0.813 |
ACVR2A |
0.800 | -0.065 | -2 | 0.811 |
BRAF |
0.800 | -0.104 | -4 | 0.669 |
MEK5 |
0.800 | -0.150 | 2 | 0.747 |
MEKK2 |
0.800 | -0.084 | 2 | 0.737 |
NEK11 |
0.799 | -0.037 | 1 | 0.735 |
PKACA |
0.799 | 0.051 | -2 | 0.616 |
P70S6K |
0.799 | 0.015 | -3 | 0.675 |
GRK4 |
0.798 | -0.222 | -2 | 0.834 |
ACVR2B |
0.798 | -0.082 | -2 | 0.823 |
LOK |
0.797 | 0.092 | -2 | 0.799 |
PERK |
0.797 | -0.141 | -2 | 0.842 |
MAP3K15 |
0.797 | 0.022 | 1 | 0.690 |
TNIK |
0.797 | 0.087 | 3 | 0.831 |
GCK |
0.797 | 0.059 | 1 | 0.726 |
PLK3 |
0.796 | -0.121 | 2 | 0.665 |
ROCK2 |
0.796 | 0.117 | -3 | 0.784 |
PDK1 |
0.796 | -0.015 | 1 | 0.740 |
KHS2 |
0.796 | 0.126 | 1 | 0.725 |
KHS1 |
0.795 | 0.113 | 1 | 0.705 |
PINK1 |
0.795 | -0.066 | 1 | 0.778 |
AURA |
0.795 | -0.037 | -2 | 0.587 |
PASK |
0.795 | -0.017 | -3 | 0.809 |
CAMK1A |
0.795 | 0.066 | -3 | 0.659 |
AKT3 |
0.795 | 0.062 | -3 | 0.613 |
HGK |
0.795 | 0.031 | 3 | 0.823 |
MEKK3 |
0.795 | -0.173 | 1 | 0.710 |
MRCKB |
0.795 | 0.087 | -3 | 0.736 |
DAPK3 |
0.794 | 0.027 | -3 | 0.786 |
SGK1 |
0.794 | 0.063 | -3 | 0.592 |
TLK1 |
0.794 | -0.130 | -2 | 0.863 |
MAPKAPK5 |
0.794 | -0.100 | -3 | 0.657 |
HPK1 |
0.794 | 0.059 | 1 | 0.723 |
MRCKA |
0.793 | 0.079 | -3 | 0.746 |
NEK4 |
0.793 | -0.040 | 1 | 0.685 |
MEKK6 |
0.793 | -0.009 | 1 | 0.677 |
BMPR1A |
0.793 | -0.013 | 1 | 0.644 |
GAK |
0.792 | -0.013 | 1 | 0.709 |
GRK2 |
0.792 | -0.082 | -2 | 0.737 |
MINK |
0.792 | 0.006 | 1 | 0.696 |
MST2 |
0.791 | -0.044 | 1 | 0.711 |
NEK8 |
0.791 | -0.122 | 2 | 0.764 |
GSK3A |
0.790 | 0.063 | 4 | 0.382 |
MST1 |
0.790 | 0.014 | 1 | 0.699 |
EEF2K |
0.790 | -0.011 | 3 | 0.791 |
LRRK2 |
0.790 | -0.001 | 2 | 0.779 |
CHK2 |
0.790 | 0.019 | -3 | 0.636 |
DMPK1 |
0.790 | 0.116 | -3 | 0.766 |
LKB1 |
0.789 | -0.073 | -3 | 0.791 |
YSK1 |
0.788 | 0.027 | 2 | 0.778 |
NEK1 |
0.788 | -0.025 | 1 | 0.678 |
SBK |
0.788 | 0.081 | -3 | 0.563 |
SLK |
0.787 | 0.018 | -2 | 0.748 |
PAK5 |
0.787 | -0.016 | -2 | 0.591 |
BUB1 |
0.787 | 0.071 | -5 | 0.698 |
IRAK1 |
0.786 | -0.199 | -1 | 0.775 |
CK1E |
0.785 | -0.060 | -3 | 0.494 |
DAPK1 |
0.785 | -0.010 | -3 | 0.763 |
GSK3B |
0.784 | -0.030 | 4 | 0.375 |
ROCK1 |
0.784 | 0.081 | -3 | 0.749 |
PAK4 |
0.784 | -0.017 | -2 | 0.596 |
CAMKK2 |
0.783 | -0.144 | -2 | 0.738 |
CAMKK1 |
0.783 | -0.210 | -2 | 0.738 |
CRIK |
0.781 | 0.086 | -3 | 0.691 |
PBK |
0.781 | -0.005 | 1 | 0.635 |
NEK3 |
0.781 | -0.051 | 1 | 0.670 |
HASPIN |
0.781 | 0.052 | -1 | 0.720 |
TTBK1 |
0.780 | -0.195 | 2 | 0.536 |
VRK1 |
0.779 | -0.157 | 2 | 0.747 |
TAK1 |
0.778 | -0.163 | 1 | 0.711 |
TAO1 |
0.778 | 0.035 | 1 | 0.668 |
CK1D |
0.777 | -0.068 | -3 | 0.447 |
PKG1 |
0.775 | 0.009 | -2 | 0.589 |
MEK2 |
0.775 | -0.198 | 2 | 0.720 |
CK1A2 |
0.773 | -0.076 | -3 | 0.446 |
BIKE |
0.773 | 0.008 | 1 | 0.601 |
STK33 |
0.773 | -0.133 | 2 | 0.528 |
CK1G1 |
0.772 | -0.101 | -3 | 0.482 |
TTK |
0.771 | -0.040 | -2 | 0.840 |
MYO3B |
0.771 | -0.004 | 2 | 0.782 |
RIPK2 |
0.771 | -0.233 | 1 | 0.671 |
GRK3 |
0.771 | -0.109 | -2 | 0.685 |
MYO3A |
0.770 | -0.008 | 1 | 0.694 |
ASK1 |
0.769 | -0.093 | 1 | 0.683 |
CK2A2 |
0.769 | -0.051 | 1 | 0.609 |
OSR1 |
0.767 | -0.085 | 2 | 0.733 |
AAK1 |
0.763 | 0.045 | 1 | 0.518 |
PLK2 |
0.763 | -0.127 | -3 | 0.703 |
CK2A1 |
0.759 | -0.066 | 1 | 0.599 |
PDHK3_TYR |
0.758 | 0.099 | 4 | 0.880 |
TESK1_TYR |
0.757 | 0.100 | 3 | 0.844 |
LIMK2_TYR |
0.756 | 0.173 | -3 | 0.864 |
PKMYT1_TYR |
0.753 | 0.058 | 3 | 0.817 |
ALPHAK3 |
0.750 | -0.135 | -1 | 0.762 |
MAP2K7_TYR |
0.749 | -0.110 | 2 | 0.775 |
PDHK4_TYR |
0.749 | -0.009 | 2 | 0.782 |
STLK3 |
0.748 | -0.202 | 1 | 0.664 |
MAP2K4_TYR |
0.746 | -0.112 | -1 | 0.870 |
PINK1_TYR |
0.746 | -0.113 | 1 | 0.738 |
LIMK1_TYR |
0.746 | -0.001 | 2 | 0.781 |
RET |
0.744 | -0.066 | 1 | 0.708 |
MAP2K6_TYR |
0.744 | -0.094 | -1 | 0.870 |
YANK3 |
0.743 | -0.118 | 2 | 0.324 |
BMPR2_TYR |
0.742 | -0.079 | -1 | 0.841 |
PDHK1_TYR |
0.742 | -0.124 | -1 | 0.881 |
MST1R |
0.742 | -0.085 | 3 | 0.797 |
EPHA6 |
0.741 | -0.050 | -1 | 0.831 |
TYK2 |
0.740 | -0.150 | 1 | 0.697 |
ROS1 |
0.740 | -0.086 | 3 | 0.756 |
JAK2 |
0.739 | -0.112 | 1 | 0.705 |
DDR1 |
0.739 | -0.044 | 4 | 0.848 |
TNNI3K_TYR |
0.738 | 0.026 | 1 | 0.674 |
TYRO3 |
0.738 | -0.131 | 3 | 0.783 |
CSF1R |
0.737 | -0.107 | 3 | 0.778 |
NEK10_TYR |
0.736 | -0.029 | 1 | 0.635 |
TNK1 |
0.735 | -0.018 | 3 | 0.749 |
EPHB4 |
0.734 | -0.116 | -1 | 0.827 |
JAK3 |
0.733 | -0.114 | 1 | 0.699 |
TNK2 |
0.733 | -0.057 | 3 | 0.762 |
JAK1 |
0.732 | -0.054 | 1 | 0.678 |
ABL2 |
0.731 | -0.100 | -1 | 0.798 |
KDR |
0.730 | -0.086 | 3 | 0.745 |
FGFR1 |
0.729 | -0.090 | 3 | 0.759 |
INSRR |
0.729 | -0.120 | 3 | 0.721 |
PDGFRB |
0.729 | -0.157 | 3 | 0.789 |
FGFR2 |
0.728 | -0.113 | 3 | 0.768 |
YES1 |
0.728 | -0.125 | -1 | 0.836 |
TXK |
0.728 | -0.061 | 1 | 0.680 |
CK1A |
0.727 | -0.120 | -3 | 0.358 |
ABL1 |
0.726 | -0.127 | -1 | 0.794 |
TEK |
0.726 | -0.103 | 3 | 0.718 |
DDR2 |
0.726 | 0.027 | 3 | 0.732 |
AXL |
0.725 | -0.126 | 3 | 0.769 |
KIT |
0.725 | -0.163 | 3 | 0.778 |
PDGFRA |
0.724 | -0.180 | 3 | 0.785 |
FGR |
0.724 | -0.201 | 1 | 0.676 |
FLT3 |
0.723 | -0.196 | 3 | 0.774 |
EPHA4 |
0.722 | -0.141 | 2 | 0.668 |
FER |
0.720 | -0.250 | 1 | 0.696 |
EPHB3 |
0.720 | -0.168 | -1 | 0.813 |
EPHB1 |
0.720 | -0.189 | 1 | 0.688 |
WEE1_TYR |
0.719 | -0.110 | -1 | 0.748 |
SRMS |
0.719 | -0.201 | 1 | 0.685 |
MET |
0.718 | -0.157 | 3 | 0.775 |
ITK |
0.718 | -0.172 | -1 | 0.772 |
ALK |
0.718 | -0.155 | 3 | 0.711 |
HCK |
0.718 | -0.217 | -1 | 0.790 |
LCK |
0.718 | -0.156 | -1 | 0.785 |
EPHB2 |
0.717 | -0.175 | -1 | 0.804 |
CK1G3 |
0.717 | -0.118 | -3 | 0.314 |
MERTK |
0.717 | -0.182 | 3 | 0.757 |
BLK |
0.716 | -0.128 | -1 | 0.803 |
LTK |
0.715 | -0.172 | 3 | 0.734 |
YANK2 |
0.715 | -0.130 | 2 | 0.343 |
FGFR3 |
0.715 | -0.156 | 3 | 0.743 |
TEC |
0.714 | -0.156 | -1 | 0.724 |
EPHA1 |
0.714 | -0.160 | 3 | 0.756 |
EPHA7 |
0.713 | -0.154 | 2 | 0.669 |
FLT1 |
0.713 | -0.179 | -1 | 0.799 |
INSR |
0.712 | -0.184 | 3 | 0.703 |
FLT4 |
0.712 | -0.199 | 3 | 0.723 |
EPHA3 |
0.711 | -0.185 | 2 | 0.646 |
PTK2B |
0.711 | -0.102 | -1 | 0.770 |
BMX |
0.711 | -0.151 | -1 | 0.686 |
NTRK1 |
0.711 | -0.257 | -1 | 0.804 |
BTK |
0.711 | -0.274 | -1 | 0.745 |
ERBB2 |
0.710 | -0.221 | 1 | 0.672 |
NTRK2 |
0.710 | -0.242 | 3 | 0.739 |
FRK |
0.709 | -0.192 | -1 | 0.805 |
NTRK3 |
0.707 | -0.195 | -1 | 0.755 |
MATK |
0.706 | -0.157 | -1 | 0.749 |
FYN |
0.704 | -0.164 | -1 | 0.756 |
EPHA5 |
0.704 | -0.167 | 2 | 0.654 |
PTK6 |
0.704 | -0.299 | -1 | 0.716 |
LYN |
0.703 | -0.213 | 3 | 0.698 |
EGFR |
0.702 | -0.153 | 1 | 0.590 |
EPHA8 |
0.702 | -0.171 | -1 | 0.784 |
CSK |
0.701 | -0.204 | 2 | 0.674 |
FGFR4 |
0.700 | -0.171 | -1 | 0.757 |
MUSK |
0.700 | -0.156 | 1 | 0.577 |
SRC |
0.695 | -0.203 | -1 | 0.774 |
PTK2 |
0.694 | -0.118 | -1 | 0.725 |
IGF1R |
0.692 | -0.204 | 3 | 0.642 |
EPHA2 |
0.691 | -0.180 | -1 | 0.734 |
ERBB4 |
0.687 | -0.144 | 1 | 0.592 |
SYK |
0.686 | -0.168 | -1 | 0.717 |
CK1G2 |
0.686 | -0.146 | -3 | 0.404 |
FES |
0.676 | -0.209 | -1 | 0.678 |
ZAP70 |
0.673 | -0.133 | -1 | 0.649 |